0001354866 Byrna Technologies Inc. false --11-30 Q2 2024 24,788 0.001 0.001 5,000,000 5,000,000 0 0 0.001 0.001 50,000,000 50,000,000 24,964,787 22,776,895 24,168,014 22,002,027 2,187,892 2,165,987 2 0 0.1 http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember 5 1 3 3 0.1 0.1 33.33 33.33 33.33 0.1 February 29, 2028 July 31, 2025 January 31, 2027 1 false false false true April 8, 2024 100,000 December 31, 2024 Bryan Ganz Chief Executive Officer 00013548662023-12-012024-05-31 xbrli:shares 00013548662024-07-09 iso4217:USD 00013548662024-05-31 00013548662023-11-30 iso4217:USDxbrli:shares 00013548662024-03-012024-05-31 00013548662023-03-012023-05-31 00013548662022-12-012023-05-31 00013548662022-11-30 00013548662023-05-31 0001354866us-gaap:CommonStockMember2024-02-29 0001354866us-gaap:AdditionalPaidInCapitalMember2024-02-29 0001354866us-gaap:TreasuryStockCommonMember2024-02-29 0001354866us-gaap:RetainedEarningsMember2024-02-29 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-29 00013548662024-02-29 0001354866us-gaap:CommonStockMember2024-03-012024-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2024-03-012024-05-31 0001354866us-gaap:TreasuryStockCommonMember2024-03-012024-05-31 0001354866us-gaap:RetainedEarningsMember2024-03-012024-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-012024-05-31 0001354866us-gaap:CommonStockMember2024-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2024-05-31 0001354866us-gaap:TreasuryStockCommonMember2024-05-31 0001354866us-gaap:RetainedEarningsMember2024-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-31 0001354866us-gaap:CommonStockMember2023-02-28 0001354866us-gaap:AdditionalPaidInCapitalMember2023-02-28 0001354866us-gaap:TreasuryStockCommonMember2023-02-28 0001354866us-gaap:RetainedEarningsMember2023-02-28 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-28 00013548662023-02-28 0001354866us-gaap:CommonStockMember2023-03-012023-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2023-03-012023-05-31 0001354866us-gaap:TreasuryStockCommonMember2023-03-012023-05-31 0001354866us-gaap:RetainedEarningsMember2023-03-012023-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-012023-05-31 0001354866us-gaap:CommonStockMember2023-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2023-05-31 0001354866us-gaap:TreasuryStockCommonMember2023-05-31 0001354866us-gaap:RetainedEarningsMember2023-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-31 0001354866us-gaap:CommonStockMember2023-11-30 0001354866us-gaap:AdditionalPaidInCapitalMember2023-11-30 0001354866us-gaap:TreasuryStockCommonMember2023-11-30 0001354866us-gaap:RetainedEarningsMember2023-11-30 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-11-30 0001354866us-gaap:CommonStockMember2023-12-012024-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2023-12-012024-05-31 0001354866us-gaap:TreasuryStockCommonMember2023-12-012024-05-31 0001354866us-gaap:RetainedEarningsMember2023-12-012024-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-012024-05-31 0001354866us-gaap:CommonStockMember2022-11-30 0001354866us-gaap:AdditionalPaidInCapitalMember2022-11-30 0001354866us-gaap:TreasuryStockCommonMember2022-11-30 0001354866us-gaap:RetainedEarningsMember2022-11-30 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-11-30 0001354866us-gaap:CommonStockMember2022-12-012023-05-31 0001354866us-gaap:AdditionalPaidInCapitalMember2022-12-012023-05-31 0001354866us-gaap:TreasuryStockCommonMember2022-12-012023-05-31 0001354866us-gaap:RetainedEarningsMember2022-12-012023-05-31 0001354866us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-012023-05-31 xbrli:pure utr:sqft 0001354866byrn:FortWayneIndianaMember2024-05-31 0001354866byrn:PretoriaSouthAfricaMember2024-05-31 0001354866byrn:ByrnaLatamMember2023-01-10 0001354866byrn:FusadyMemberbyrn:ByrnaLatamMember2023-01-10 00013548662022-12-012023-08-31 0001354866byrn:ByrnaLatamMember2023-01-102023-01-10 0001354866byrn:ByrnaLatamMember2024-03-312024-05-31 0001354866byrn:ByrnaLatamMember2023-12-012024-05-31 0001354866byrn:ByrnaLatamMember2023-03-012023-05-31 0001354866byrn:ByrnaLatamMember2022-12-012023-05-31 0001354866byrn:ByrnaLatamMember2023-01-31 thunderdome:item 00013548662023-01-312023-01-31 0001354866byrn:ByrnaLatamMember2024-05-31 utr:Y 0001354866byrn:ByrnaLatamMember2023-01-012023-01-31 00013548662024-05-312024-05-31 0001354866byrn:WholesaleDealerDistributorsAndLargeEndUsersMember2024-03-012024-05-31 0001354866byrn:WholesaleDealerDistributorsAndLargeEndUsersMember2023-03-012023-05-31 0001354866byrn:WholesaleDealerDistributorsAndLargeEndUsersMember2023-12-012024-05-31 0001354866byrn:WholesaleDealerDistributorsAndLargeEndUsersMember2022-12-012023-05-31 0001354866byrn:ECommerceMember2024-03-012024-05-31 0001354866byrn:ECommerceMember2023-03-012023-05-31 0001354866byrn:ECommerceMember2023-12-012024-05-31 0001354866byrn:ECommerceMember2022-12-012023-05-31 0001354866byrn:ComputerEquipmentAndSoftwareMembersrt:MinimumMember2024-05-31 0001354866byrn:ComputerEquipmentAndSoftwareMember2023-11-30 0001354866us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2024-05-31 0001354866us-gaap:FurnitureAndFixturesMember2023-11-30 0001354866us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2024-05-31 0001354866us-gaap:LeaseholdImprovementsMember2023-11-30 0001354866us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2024-05-31 0001354866us-gaap:MachineryAndEquipmentMember2023-11-30 0001354866srt:MinimumMember2024-05-31 0001354866us-gaap:PatentsMembersrt:MinimumMember2024-05-31 0001354866us-gaap:PatentsMembersrt:MaximumMember2024-05-31 0001354866us-gaap:PatentsMember2024-05-31 0001354866us-gaap:PatentsMember2023-11-30 0001354866us-gaap:TrademarksMember2024-05-31 0001354866us-gaap:TrademarksMember2023-11-30 0001354866us-gaap:CustomerListsMember2024-05-31 0001354866us-gaap:CustomerListsMember2023-11-30 0001354866byrn:The2020EquityIncentivePlan2020PlanMember2022-06-17 0001354866byrn:The2020EquityIncentivePlan2020PlanMember2023-12-012024-05-31 0001354866byrn:The2020EquityIncentivePlan2020PlanMember2022-12-012023-05-31 0001354866byrn:The2020EquityIncentivePlan2020PlanMember2024-03-012024-05-31 0001354866byrn:The2020EquityIncentivePlan2020PlanMember2023-03-012023-05-31 0001354866byrn:RestrictedStockUnitsRSUsExcludingTimebasedUnitsMember2023-12-012024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-05-312024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2024-05-312024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2024-05-312024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2024-05-31 0001354866byrn:RestrictedStockUnitsRSUsTimebasedMember2023-12-012024-05-31 0001354866byrn:RestrictedStockUnitsRSUsTimebasedMember2022-12-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2023-12-012024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2022-12-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2024-03-012024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2023-03-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2023-11-30 0001354866us-gaap:EmployeeStockOptionMemberbyrn:The2020EquityIncentivePlan2020PlanMemberbyrn:EmployeesAndDirectorsMember2023-12-012024-05-31 0001354866us-gaap:EmployeeStockOptionMemberbyrn:The2020EquityIncentivePlan2020PlanMemberbyrn:EmployeesAndDirectorsMember2022-12-012023-05-31 0001354866us-gaap:EmployeeStockOptionMemberbyrn:The2020EquityIncentivePlan2020PlanMemberbyrn:EmployeesAndDirectorsMember2024-03-012024-05-31 0001354866us-gaap:EmployeeStockOptionMemberbyrn:The2020EquityIncentivePlan2020PlanMemberbyrn:EmployeesAndDirectorsMember2023-03-012023-05-31 0001354866us-gaap:EmployeeStockOptionMember2024-05-31 0001354866us-gaap:EmployeeStockOptionMember2024-03-012024-05-31 0001354866us-gaap:EmployeeStockOptionMember2023-12-012024-05-31 0001354866us-gaap:EmployeeStockOptionMember2024-03-012024-05-31 0001354866us-gaap:EmployeeStockOptionMember2023-03-012023-05-31 0001354866us-gaap:EmployeeStockOptionMember2023-12-012024-05-31 0001354866us-gaap:EmployeeStockOptionMember2022-03-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2024-03-012024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2023-03-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2023-12-012024-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMember2022-03-012023-05-31 00013548662022-03-012023-05-31 0001354866us-gaap:RestrictedStockUnitsRSUMemberbyrn:ChiefTechnologyOfficerMember2021-12-012022-11-30 0001354866us-gaap:RestrictedStockUnitsRSUMemberbyrn:ChiefTechnologyOfficerMember2022-12-012023-11-30 0001354866byrn:EachOfFourIndividualInvestorsMemberbyrn:FusadyMember2024-05-31 0001354866byrn:EachOfFourIndividualInvestorsMemberbyrn:BersaSaMember2024-05-31 0001354866us-gaap:RelatedPartyMemberbyrn:BersaSaMember2024-03-012024-05-31 0001354866us-gaap:RelatedPartyMemberbyrn:BersaSaMember2023-12-012024-05-31 0001354866us-gaap:RelatedPartyMemberbyrn:BersaSaMember2023-03-012023-05-31 0001354866us-gaap:RelatedPartyMemberbyrn:BersaSaMember2022-12-012023-05-31 0001354866byrn:BersaSaMember2024-05-31 0001354866byrn:BersaSaMember2023-11-30 0001354866byrn:WilmingtonAndoverMassachusettsMember2024-03-012024-05-31 0001354866byrn:FormerFortWayneFacilityMemberbyrn:FortWayneIndianaMember2024-03-012024-05-31 0001354866byrn:LasVegasNevadaMember2024-03-012024-05-31 0001354866byrn:AndreBuysMember2018-04-13 0001354866byrn:FintailProjectilesMember2018-04-132018-04-13 0001354866us-gaap:RestrictedStockUnitsRSUMemberbyrn:ChiefTechnologyOfficerMember2022-01-07 0001354866us-gaap:RestrictedStockUnitsRSUMemberbyrn:ChiefTechnologyOfficerMember2023-06-072023-06-07 0001354866country:US2024-03-012024-05-31 0001354866country:ZA2024-03-012024-05-31 0001354866byrn:EuropesouthAmericaasiaMember2024-03-012024-05-31 0001354866country:CA2024-03-012024-05-31 0001354866country:US2023-03-012023-05-31 0001354866country:ZA2023-03-012023-05-31 0001354866byrn:EuropesouthAmericaasiaMember2023-03-012023-05-31 0001354866country:CA2023-03-012023-05-31 0001354866country:US2023-12-012024-05-31 0001354866country:ZA2023-12-012024-05-31 0001354866byrn:EuropesouthAmericaasiaMember2023-12-012024-05-31 0001354866country:CA2023-12-012024-05-31 0001354866country:US2022-12-012023-05-31 0001354866country:ZA2022-12-012023-05-31 0001354866byrn:EuropesouthAmericaasiaMember2022-12-012023-05-31 0001354866country:CA2022-12-012023-05-31
 

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2024

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File No. 333-132456 

 

Byrna Technologies Inc.

(Exact name of registrant as specified in its charter)

   

Delaware

 

71-1050654

(State or other jurisdiction of incorporation or

 

(I.R.S. Employer Identification No.)

organization)

  

100 Burtt Road, Suite 115

Andover, MA 01810

(Address of Principal Executive Offices, including zip code)

   

(978) 868-5011

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001, par value per share

BYRN

Nasdaq Capital Market 

 

Securities registered pursuant to Section 12(g) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ☐    Accelerated filer  ☐     

Non-accelerated filer  ☒       Smaller reporting company       

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes No ☒

 

As of July 9, 2024, the Company had 22,776,895 outstanding shares of common stock.

 

 

 

 

TABLE OF CONTENTS

 

 

Page

   

PART 1  FINANCIAL INFORMATION

2

     

Item 1.

Condensed Consolidated Financial Statements

2

     
 

Condensed Consolidated Balance Sheets as of May 31, 2024 (unaudited) and November 30, 2023

2

     
 

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Six Months Ended May 31, 2024 and 2023 (unaudited)

3

     
 

Condensed Consolidated Statements of Cash Flows for the Six Months Ended May 31, 2024 and 2023 (unaudited)

4

     
 

Condensed Consolidated Statements of Changes in Stockholders Equity for the Three and Six Months Ended May 31, 2024 and 2023 (unaudited)

5

     
 

Notes to Condensed Consolidated Financial Statements

6

     

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

18

     

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

25

     

Item 4.

Controls and Procedures

25

     

PART II  OTHER INFORMATION

26

     

Item 1.

Legal Proceedings

26

     

Item 1A.

Risk Factors

26

     

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

26

     

Item 3.

Defaults Upon Senior Securities

26

     

Item 4.

Mine Safety Disclosures

26

     

Item 5.

Other Information

26

     

Item 6.

Exhibits

27

     

SIGNATURES

28

 

 

 

 

1

 

PART 1 FINANCIAL INFORMATION

 

ITEM 1.

Condensed Consolidated Financial Statements

 

 

BYRNA TECHNOLOGIES INC. 

Condensed Consolidated Balance Sheets 

(Amounts in thousands, except share and per share data)

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 
  

Unaudited

     

ASSETS

        

CURRENT ASSETS

        

Cash and cash equivalents

 $24,788  $20,498 

Accounts receivable, net

  1,635   2,945 

Inventory, net

  15,500   13,890 

Prepaid expenses and other current assets

  1,779   868 

Total current assets

  43,702   38,201 

LONG TERM ASSETS

        

Intangible assets, net

  3,441   3,583 

Deposits for equipment

  1,706   1,163 

Right-of-use asset, net

  1,473   1,805 

Property and equipment, net

  3,408   3,803 

Goodwill

  2,265   2,258 

Loan to joint venture

  1,493   1,473 

Other assets

  35   28 

TOTAL ASSETS

 $57,523  $52,314 
         

LIABILITIES

        

CURRENT LIABILITIES

        

Accounts payable and accrued liabilities

 $9,207  $6,158 

Operating lease liabilities, current

  552   644 

Deferred revenue, current

  1,407   1,844 

Total current liabilities

  11,166   8,646 

LONG TERM LIABILITIES

        

Deferred revenue, non-current

  45   91 

Operating lease liabilities, non-current

  999   1,258 

Total liabilities

  12,210   9,995 
         

COMMITMENTS AND CONTINGENCIES (NOTE 19)

          
         

STOCKHOLDERS’ EQUITY

        

Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued

      

Common stock, $0.001 par value, 50,000,000 shares authorized. 24,964,787 shares issued and 22,776,895 shares outstanding as of May 31, 2024, and 24,168,014 shares issued and 22,002,027 outstanding as of November 30, 2023

  24   24 

Additional paid-in capital

  131,550   130,426 

Treasury stock (2,187,892 and 2,165,987 shares purchased as of May 31, 2024 and November 30, 2023, respectively)

  (17,753)  (17,500)

Accumulated deficit

  (67,481)  (69,575)

Accumulated other comprehensive loss

  (1,027)  (1,056)
         

Total Stockholders’ Equity

  45,313   42,319 
         

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 $57,523  $52,314 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

2

 

BYRNA TECHNOLOGIES INC.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Amounts in thousands except share and per share data)

(Unaudited)

 

 

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Net revenue

 $20,269  $11,508  $36,923  $19,919 

Cost of goods sold

  7,709   5,309   14,724   8,475 

Gross profit

  12,560   6,199   22,199   11,444 

Operating expenses

  10,647   7,191   20,450   14,431 

INCOME (LOSS) FROM OPERATIONS

  1,913   (992)  1,749   (2,987)

OTHER INCOME (EXPENSE)

                

Foreign currency transaction loss

  (220)  (46)  (279)  (184)

Interest income

  323   143   604   286 

Income (loss) from joint venture

  62   (171)  20   (338)

Other income (expense)

  2   (33)  3   (87)

INCOME (LOSS) BEFORE INCOME TAXES

  2,080   (1,099)  2,097   (3,310)

Income tax benefit (expense)

  (3)  (17)  (3)  41 

NET INCOME (LOSS)

  2,077   (1,116)  2,094   (3,269)
                 

Foreign currency translation adjustment for the period

  144   (641)  29   (1,226)

COMPREHENSIVE INCOME (LOSS)

 $2,221  $(1,757) $2,123  $(4,495)
                 

Basic net income (loss) per share

 $0.09  $(0.05) $0.09  $(0.15)

Diluted net income (loss) per share

 $0.09  $(0.05) $0.09  $(0.15)
                 

Weighted-average number of common shares outstanding - basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Weighted-average number of common shares outstanding - diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

3

 

 

BYRNA TECHNOLOGIES INC. 

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands) 

(Unaudited) 

 

 

   

For the Six Months Ended

 
    May 31,  
   

2024

   

2023

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income (loss) for the period

  $ 2,094     $ (3,269 )

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

               

Stock-based compensation expense

    1,796       2,951  

Depreciation and amortization

    675       582  

Amortization of debt issuance costs

    4        

Amortization of right-of-use asset

    332       332  

Loss (income) from joint venture

    (20 )     338  

Impairment loss

          176  

Changes in assets and liabilities:

               

Accounts receivable

    1,310       1,258  

Deferred revenue

    (483 )     (175 )

Inventory

    (1,610 )     (2,677 )

Prepaid expenses and other current assets

    (910 )     (77 )

Other assets

          (80 )

Accounts payable and accrued liabilities

    3,049       (1,369 )

Operating lease liabilities

    (362 )     (352 )

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

    5,875       (2,362 )
                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Purchases of property and equipment

    (693 )     (148 )

Equity method investment in joint venture

          (520 )

Loan to joint venture

          (1,556 )

NET CASH USED IN INVESTING ACTIVITIES

    (693 )     (2,224 )
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Proceeds from stock option exercises

    128        

Repurchase of common stock

    (253 )      

Payment of taxes withheld on issuance of restricted stock units

    (800 )      

NET CASH USED IN FINANCING ACTIVITIES

    (925 )      

Effects of foreign currency exchange rate changes

    33       (122 )

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS FOR THE PERIOD

    4,290       (4,708 )

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

    20,498       20,068  

CASH AND CASH EQUIVALENTS END OF PERIOD

  $ 24,788     $ 15,360  

 

 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

4

 

 

BYRNA TECHNOLOGIES INC. 

Condensed Consolidated Statements of Changes in Stockholders Equity

For the Three and Six Months Ended May 31, 2024 and 2023

(Amounts in thousands except share numbers)

(Unaudited)

 

                   

Additional

   

Treasury

           

Accumulated Other

         
   

Common Stock

   

Paid-in

   

Stock

   

Accumulated

   

Comprehensive

         
   

Shares

   

$

   

Capital

   

Shares

   

$

   

Deficit

   

Loss

   

Total

 

Balance, February 29, 2024

    24,375,754     $ 24     $ 131,374       (2,165,987 )   $ (17,500 )   $ (69,558 )   $ (1,171 )   $ 43,169  

Stock-based compensation

                858                               858  

Issuance of common stock pursuant to exercise of stock options

    39,465             118                               118  

Issuance of common stock pursuant to vesting of restricted stock units

    549,568             (800 )                             (800 )

Repurchase of common stock

                      (21,905 )     (253 )                 (253 )

Net income

                                  2,077             2,077  

Foreign currency translation

                                        144       144  

Balance, May 31, 2024

    24,964,787     $ 24     $ 131,550       (2,187,892 )   $ (17,753 )   $ (67,481 )   $ (1,027 )   $ 45,313  
                                                                 

Balance, February 28, 2023

    24,032,248     $ 23     $ 126,938       (2,165,987 )   $ (17,500 )   $ (63,537 )   $ (1,205 )   $ 44,719  

Stock-based compensation

                1,487                               1,487  

Net loss

                                  (1,116 )           (1,116 )

Foreign currency translation

                                        (641 )     (641 )

Balance, May 31, 2023

    24,032,248     $ 23     $ 128,425       (2,165,987 )   $ (17,500 )   $ (64,653 )   $ (1,846 )   $ 44,449  

 

                   

Additional

   

Treasury

           

Accumulated Other

         
   

Common Stock

   

Paid-in

   

Stock

   

Accumulated

   

Comprehensive

         
   

Shares

   

$

   

Capital

   

Shares

   

$

   

Deficit

   

Loss

   

Total

 

Balance, November 30, 2023

    24,168,014     $ 24     $ 130,426       (2,165,987 )   $ (17,500 )   $ (69,575 )   $ (1,056 )   $ 42,319  

Stock-based compensation

                1,796                               1,796  

Issuance of common stock pursuant to exercise of stock options

    207,432             128                               128  

Issuance of common stock pursuant to vesting of restricted stock units

    589,341             (800 )                             (800 )

Repurchase of common stock

                      (21,905 )     (253 )                 (253 )

Net income

                                  2,094             2,094  

Foreign currency translation

                                        29       29  

Balance, May 31, 2024

    24,964,787     $ 24     $ 131,550       (2,187,892 )   $ (17,753 )   $ (67,481 )   $ (1,027 )   $ 45,313  
                                                                 

Balance, November 30, 2022

    24,018,612     $ 23     $ 125,474       (2,165,987 )   $ (17,500 )   $ (61,383 )   $ (620 )   $ 45,994  

Issuance of common stock pursuant to vesting of restricted stock units

    13,636                                            

Stock-based compensation

                2,951                               2,951  

Net loss

                                  (3,269 )           (3,269 )

Foreign currency translation

                                        (1,226 )     (1,226 )

Balance, May 31, 2023

    24,032,248     $ 23     $ 128,425       (2,165,987 )   $ (17,500 )   $ (64,653 )   $ (1,846 )   $ 44,449  

 

See accompanying notes to the unaudited condensed consolidated financial statements.
 

5

 

BYRNA TECHNOLOGIES INC. 

Notes to Condensed Consolidated Financial Statements (Unaudited)

For the three and six months ended May 31, 2024 and 2023

 

1.

NATURE OF OPERATIONS

 

Byrna Technologies Inc. (the “Company” or “Byrna”) is a technology company, specializing in next generation alternatives to traditional firearms without the risk of taking a life.  The Company's launchers can be used for self-defense and personal security by consumers in all 50 states without a firearms license, subject to local regulations. The Company also sells accessories, pepper sprays, and other personal safety tools. Most of the sales are to consumers in the United States via our Company e-commerce site, the Amazon storefront, or the brick and mortar location in Las Vegas, and through retailers, including big box stores.  The Company's products also may be sold to private security and public security officers. Since 2020, the Company has not manufactured or sold any products to or for use by the military. The Company operates two manufacturing facilities, a 30,000 square foot facility located in Fort Wayne, Indiana and a 20,000 square foot manufacturing facility located in Pretoria, South Africa.

 

On January 10, 2023, the Company created a new joint venture ("Byrna LATAM") with Fusady S.A. ("Fusady") located in Uruguay, to expand the Company's operations and presence in South American markets.  The Company holds 51% of the stock in Byrna LATAM, and the remaining 49% of stock in Byrna LATAM is held by Fusady.  See Note 7, "Investment in Joint Venture" for additional information. 

 

 

2.

OPERATIONS AND MANAGEMENT PLANS

 

From inception to May 31, 2024, the Company has incurred an accumulated deficit of approximately $67.5 million.  The Company has funded operations through the issuance of common stock.  The Company generated net income of $2.1 million for the six months ended May 31, 2024.  The Company’s future success is dependent upon its ability to continue to raise sufficient capital or generate adequate revenues, to cover its ongoing operating expenses, and also to continue to develop and be able to profitably market its products. 

 

Management projects that all cash needs will be met beyond one year from the time these financial statements are issued.

 

3.

BASIS OF PRESENTATION

 

These unaudited condensed consolidated financial statements for the three and six months ended May 31, 2024 and 2023 include the accounts of the Company and its subsidiaries. These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles in the United States of America (“GAAP”); however, such information reflects all adjustments consisting solely of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the results for the interim periods.   All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto together with management’s discussion and analysis of financial condition and results of operations contained in the Company's annual report on Form 10-K for the year ended November 30, 2023. In the opinion of management, the accompanying unaudited condensed consolidated financial statements, the results of its operations for the three and six months ended May 31, 2024 and 2023, and its cash flows for the six months ended May 31, 2024 and 2023 are not necessarily indicative of results to be expected for the full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

 

6

 
 

4.

USE OF ESTIMATES

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Future events and their effects cannot be determined with certainty. Therefore, the determination of estimates requires the exercise of judgment. Actual results could differ from those estimates, and any such differences may be material to our condensed consolidated financial statements. Significant estimates include assumptions about stock-based compensation expense, valuation for deferred tax assets, incremental borrowing rate on leases, valuation and carrying value of goodwill and other identifiable intangible assets, useful life of long-lived assets, inventory reserves, and allowance for credit losses. 

 

5.

RECENT ACCOUNTING GUIDANCE

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs"). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on the financial statements.

 

Recently Adopted Accounting Pronouncement

In 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016- 13”). The guidance changes the impairment model used to measure credit losses for most financial assets. A new forward-looking expected credit loss model will replace the existing incurred credit loss model and will impact the Company’s accounts receivables. This is expected to generally result in earlier recognition of allowances for credit losses. The Company adopted ASU 2016-13 on December 1, 2023, and it did not have a material impact on the Company’s financial statements.

 

Accounting Pronouncement Issued but Not Adopted

In 2023, the FASB issued ASU 2023-09 – Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). This update standardizes categories for the effective tax rate reconciliation, requires disaggregation of income taxes and additional income tax-related disclosures. This update is required to be effective for the Company for fiscal periods beginning after December 15, 2025. The Company is evaluating the effect that ASU 2023-09 will have on its financial statements and disclosures.

 

The FASB also issued ASU 2023-07: Segment Reporting Topic 280 - Improvements to Reportable Segment Disclosures. This update requires expanded annual and interim disclosures for significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. This update will be effective for fiscal years beginning after December 15, 2024, and is to be applied retrospectively to all periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the effect that ASU 2023-07 will have on its financial statements and disclosures and believes it will not have a material impact on the Company’s consolidated financial statements.

 

On March 21, 2024, the FASB issued Accounting Standards Update (ASU) 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards, which provides illustrative guidance to help entities determine whether profits interest and similar awards should be accounted for as share-based payment arrangements within the scope of ASC Topic 718, CompensationStock Compensation.  The Company believes it will not have a material impact on the Company’s consolidated financial statements.

 

 

 

7

 
 
6.

Goodwill

 

Goodwill resulting from a business combination is not amortized but is reviewed for impairment annually or more frequently when events or changes in circumstances occur that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company has the option to perform a qualitative assessment over goodwill when events occur or circumstances change that would, more likely than not, reduce the fair value of a reporting unit or to bypass the qualitative assessment in any period and proceed directly to performing the quantitative goodwill impairment test. If the Company concludes, based on the qualitative assessment, that the carrying value of a reporting unit would more likely than not exceed its fair value, a quantitative assessment is performed which is based upon a comparison of the reporting unit’s fair value to its carrying value. The fair values used in this evaluation are estimated by the Company based upon future discounted cash flow projections for the reporting unit. An impairment charge is recognized for any amount by which the carrying amount of goodwill exceeds its fair value.

 

The Company performs its annual review for impairment during the third quarter of each year. The Company assesses goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s operations constitute a single reporting unit and goodwill is assessed for impairment at the Company level as a whole. The Company has determined that, as of August 31, 2023, there was no impairment of goodwill, and there have been no events through May 31, 2024 that would indicate that a potential impairment to Goodwill has occurred.

 

7.

 INVESTMENT IN JOINT VENTURE


In January 2023, the Company acquired a 51% ownership interest in Byrna LATAM, a corporate joint venture formed to expand the Company’s operations and presence in South American markets, for $0.5 million. The Company accounts for the investment in the joint venture using the equity method since the Company does not have voting control of Byrna LATAM.  Additionally, the Company does not have substantive participating rights that would result in the Company having control of Byrna LATAM. The Company recorded its share of the joint venture’s income during the three and six months ended May 31, 2024 of less than $0.1 million and losses of $0.2 million and $0.3 million during the three and six months ended May 31, 2023, respectively, in the Consolidated Statements of Operations and Comprehensive Income (Loss) as income (loss) from joint venture. The carrying value of the Company's investment in the joint venture at May 31, 2024 and  November 30, 2023 is at zero in the Consolidated Balance Sheets.

 

In January 2023, the Company loaned $1.6 million to Byrna LATAM.  The loan bears interest at a rate equal to Secured Overnight Financing Rate ("SOFR") plus 3.0%.  The interest rate on the loan was 8.3% as of  May 31, 2024.  The principal amount and accrued interest on the loan amount must be repaid within five years from the date of the loan, or January 10, 2028.  Interest income related to the loan receivable was approximately $0.03 million and $0.06 million for the three and six months ended May 31, 2024, respectively.  The interest income is included in interest income in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).  The loan receivable is recorded as loan to joint venture in the Consolidated Balance Sheets. 

 

8.

 ADVERTISING COSTS

 

Advertising costs are expenses as incurred and reported in Operating Expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), and include costs of advertising, tradeshows, and other activities designed to enhance demand for the Company's products.  The Company reported advertising costs of approximately $2.5 million and $5.3 million for the three and six months ended May 31, 2024, respectively, $0.6 million and $1.5 million for the three and six months ended May 31, 2023, respectively.

 

8

 
 

9.

REVENUE, DEFERRED REVENUE AND ACCOUNTS RECEIVABLE

 

The Company generates most of its revenue through e-commerce portals to consumers, as well as wholesale distribution of its products and accessories to dealers/distributors and retail stores.  The Company also sells products to large end-users such as private security companies and law enforcement agencies.  The Company does not manufacture or sell any products regulated by the Bureau of Alcohol, Tobacco, Firearms and Explosives or for military applications. Revenue is recognized upon transfer of control of goods to the customer, which generally occurs when title to goods is passed and risk of loss transfers to the customer. Depending on the contract terms, transfer of control is upon shipment of goods to or upon the customer’s pick-up of the goods. Payment terms to customers other than e-commerce customers are generally 30-60 days for established customers, whereas new wholesale and large end-user customers have prepaid terms for their first order. The amount of revenue recognized is net of returns and discounts that the Company offers to its customers. Products purchased include a standard warranty that cannot be purchased separately. This allows customers to return defective products for repair or replacement within one year of sale. The Company also sells an extended warranty for the same terms over three years. The extended 3-year warranty can be purchased separately from the product and is classified as a service warranty. Since a warranty for the first year after sale is included and non-separable from all launcher purchases, the Company considers this extended warranty to represent a service obligation during the second and third years after sale. Therefore, the Company accumulates billings of these transactions on the balance sheet as deferred revenue, to be recognized on a straight-line basis during the second and third year after sale. The Company recognizes an estimated reserve based on its analysis of historical experience, and an evaluation of current market conditions. 

 

The Company offers e-commerce customers a 14-day money-back guarantee, which allows for a full refund of the purchase price, excluding shipping charges, within 14 days from the date of delivery.  The right of return creates a variable component to the transaction price and needs to be considered for any possible constraints. The Company estimates returns using the expected value method, as there will likely be a range of potential return amounts. The Company’s reserve for returns under the 14-day money back guarantee for the three and six months ended May 31, 2024 and 2023 was immaterial.

 

The Company does not offer a money-back guarantee to dealers or retailers. These customers  may request a return or credit for unforeseen reasons or may have agreed discounts or allowances to be netted from amounts invoiced. Accordingly, the Company reserves for returns, discounts and allowances based on past performance and on agreement terms and reports revenue net of the estimated reserve.  The Company's reserve for returns, discounts, and allowances for the three and six months ended May 31, 2024 and 2023 was immaterial.

 

The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs associated with the distribution of finished products to customers, are recorded in operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and are recognized when the product is shipped to the customer.

 

Included as cost of goods sold are costs associated with the production and procurement of products, such as labor and overhead, inbound freight costs, manufacturing depreciation, purchasing and receiving costs, and inspection costs.

 

Accounts Receivable

 

The Company records accounts receivables due from dealers/distributers, large end-users such as retail stores, security companies, and law enforcement agencies.  Accounts receivable, net of allowances, was $1.6 million, $2.9 million and $5.9 million as of  May 31, 2024 November 30, 2023, and  November 30, 2022, respectively.

 

Allowance for Expected Credit Losses

 

The Company estimates the balance of its allowance for expected credit losses. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status and makes judgments about the creditworthiness of customers based on ongoing credit evaluations. The Company also considers customer-specific information, current market conditions, and reasonable and supportable forecasts of future economic conditions. Account balances are written off against the allowance when it is determined that the receivable will not be recovered.  As of May 31, 2024 November 30, 2023, and November 30, 2022, the total allowance for credit losses recorded was $0.3 million, $0.5 million and less than $0.02 million, respectively.  

 

9

 

Deferred Revenue

 

The balance of deferred revenue, which relate to unfulfilled e-commerce orders and amounts to be recognized under extended 3-year service warranty, as of  May 31, 2024 and  May 31, 2023 was $1.5 million and $0.6 million, respectively, and $1.9 million and $0.8 million as of  November 30, 2023 and 2022, respectively.  The Company recognized warranty revenue totaling $0.1 million and $0.2 million, respectively, during the three and six months ended  May 31, 2024 and $0.08 million and $0.1 million, respectively, during the three and six months ended  May 31, 2023.  

 

Revenue Disaggregation

 

The following table presents disaggregation of the Company’s revenue by distribution channel (in thousands):

 

  

Three Months Ended

  

Six Months Ended

 
  May 31,  May 31, 

Distribution channel

 

2024

  

2023

  

2024

  

2023

 

Wholesale (dealer/distributors)

 $5,177  $4,669  $8,731  $6,968 

E-commerce (direct to consumers)

  15,092   6,839   28,192   12,951 

Total

 $20,269  $11,508  $36,923  $19,919 
   
 

10.

INVENTORY

 

The following table summarizes inventory (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Raw materials

 $9,645  $7,543 

Work in process

  2,122   2,439 

Finished goods

  3,733   3,908 

Total

 $15,500  $13,890 

 

 

 

 

 

11.

PROPERTY AND EQUIPMENT

 

The following table summarizes cost and accumulated depreciation (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Computer equipment and software

 $814  $817 

Furniture and fixtures

  274   273 

Leasehold improvements

  990   989 

Machinery and equipment

  3,567   3,425 
   5,645   5,504 

Less: accumulated depreciation

  2,237   1,701 

Total

 $3,408  $3,803 

 

The Company recognized $0.5 million and $0.4 million in depreciation expense during the six months ended May 31, 2024 and 2023, respectively.  The Company recognized $0.3 million and $0.2 million in depreciation expense during the three months ended May 31, 2024 and 2023, respectively.  Depreciation expense is presented in the operating expenses and within cost of goods sold in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

At May 31, 2024 and November 30, 2023, the Company had deposits of $1.7   million and $1.2  million, respectively, with vendors primarily for supply of machinery (molds) and equipment where the vendors have not completed the supply of these assets and is presented as Deposits for equipment in the Condensed Consolidated Balance Sheets.

 

 

 

10

 
 

12.

INTANGIBLE ASSETS

 

The components of intangible assets were as follows (in thousands):

 

     

Balance at May 31, 2024

  

Balance at November 30, 2023

 
  

Estimated Useful Lives in Years

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Patents

 

10-17

  $3,931  $(850) $3,081  $3,931  $(723) $3,208 

Trademarks

 

Indefinite

   360      360   360      360 

Customer List

 

2

   70   (70)     70   (55)  15 

Total

    $4,361  $(920) $3,441  $4,361  $(778) $3,583 

 

The trademarks have an indefinite life and will be assessed annually for impairment.  All other intangible assets are finite-lived.

 

Intangible assets amortization expenses are recorded within operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).  Total intangible assets amortization expense for the six months ended May 31, 2024 and 2023 were $0.1  million.  Total intangible assets amortization expense for the three months ended May 31, 2024 and 2023 were less than $0.1  million. 

 

Estimated future amortization expense related to intangible assets as of May 31, 2024 are as follows (in thousands):

 

Fiscal Year Ending November 30,

    

2024 (remaining six months)

 $128 

2025

  254 

2026

  254 

2027

  254 

2028

  254 

Thereafter

  1,937 

Total

 $3,081 

 

 

13.

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Trade payables

 $6,450  $2,617 

Accrued sales and use tax

  362   834 

Accrued people costs

  1,763   2,173 

Accrued professional fees

  148   201 

Other accrued liabilities

  484   333 

Total

 $9,207  $6,158 

 

11

 
 

 

14.

STOCK-BASED COMPENSATION

 

2020 Plan

On October 23, 2020, the Company's Board of Directors approved and on November 19, 2020, the stockholders approved the Byrna Technologies Inc. 2020 Equity Incentive Plan (the “2020 Plan”). The aggregate number of shares of common stock available for issuance in connection with options and other awards granted under the 2020 Plan is 3,800,000 shares. The 2020 Plan is administered by the Compensation Committee of the Board. The Compensation Committee determines the persons to whom options to purchase shares of common stock, stock appreciation rights (“SARs”), restricted stock units (“RSUs”), and restricted or unrestricted shares of common stock may be granted. Persons eligible to receive awards under the 2020 Plan are employees, officers, directors, consultants, advisors and other individual service providers of the Company. Awards are at the discretion of the Compensation Committee.

 

The Company accounts for all stock-based payment awards granted to employees and non-employees as stock-based compensation expense at their grant date fair value. The Company’s stock-based payments include stock options, RSUs, and incentive warrants. The measurement date for employee awards is the date of grant, and stock-based compensation costs are recognized as expense over the employees’ requisite service period, on a straight-line basis. The measurement date for non-employee awards is generally the date the services were completed, resulting in financial reporting period adjustments to stock-based compensation during either the expected term or the contractual term. Stock-based compensation costs for non-employees are recognized as expense over the vesting period on a straight-line basis. Forfeitures are accounted for as they occur.

 

The fair value of each grant is estimated on the date of grant by using either the Black-Scholes, Binomial Lattice, or the quoted stock price on the date of grant, unless the awards are subject to market conditions in which case the Company uses the Monte Carlo simulation model. Due to the Company’s limited history, the expected term of the Company’s stock options granted to employees has been determined utilizing the method as prescribed by the SEC’s Staff Accounting Bulletin, Topic 14. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.

 

Stock-Based Compensation Expense

Stock-based compensation costs are recognized as expense over the employee's requisite service period, on a straight-line basis.  Total stock-based compensation expense was $1.8 million and $3.0 million for the six months ended May 31, 2024 and 2023, respectively.  Total stock-based compensation expense was $0.9 million and $1.5 million for the three months ended May 31, 2024 and 2023, respectively.  Total stock-based compensation expense was recorded in Operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

12

           

Restricted Stock Units

 

During the six months ended May 31, 2024 the Company granted 600,000 of the RSU's with a “double trigger” for vesting based on stock price and time, as follows: (1) one-third of the RSUs will be triggered when the Company’s stock trades above $6.00 on a 20-day VWAP, the second one-third of the RSUs will be triggered when the Company’s stock trades above $9.00 on a 20-day VWAP, and the final one-third of the RSUs will be triggered when the stock trades above $12.00 on a 20-day VWAP and (2) the employee must remain employed by the Company for three years from the effective date for the RSUs to vest. During the six months ended May 31, 2023, the Company did not grant "double trigger" RSUs.  In addition, the Company also granted 81,656 and 9,805 time-based RSU's during the six months ended May 31, 2024 and 2023, respectively.  Stock-based compensation expense for the RSUs for the six months ended May 31, 2024 and 2023 was $0.9 million and $2.0 million, respectively, and for the three months ended May 31, 2024 and 2023 was $0.4 million and $1.0 million, respectively.

 

The assumptions that the Company used in a Monte Carlo simulation model to determine the grant-date fair value of RSU's granted with a double trigger for the six months ended May 31, 2024 were as follows:

 

Risk free rate

  4.33%

Expected dividends

 $ 

Expected volatility

  33%

Expected life (in years)

  2.7 

Market price of the Company’s common stock on date of grant

 $6.03 
 

As of  May 31, 2024, there was $1.9 million of unrecognized stock-based compensation cost related to unvested RSUs which is expected to be recognized over a weighted average of 2.0 years. 

 

The following table summarizes the RSU activity during the six months ended May 31, 2024:

 

  

RSUs

 

Unvested and outstanding as of November 30, 2023

  976,226 

Granted

  634,513 

Settled

  (658,281)

Forfeited

  (75,250)

Unvested and outstanding at May 31, 2024

  877,208 

 

Of the 658,281 restricted units issued, 68,940 units were returned to the Company in exchange for the Company paying for the payroll withholding taxes.  For the six months ended May 31, 2024, RSUs of 589,341, net, were issued.

 

Stock Options

The Company recorded stock-based compensation expense for options granted to its employees and directors of $0.9 million and $0.9 million during the six months ended May 31, 2024 and 2023, respectively, and for the three months ended May 31, 2024 and 2023 was $0.5 million and $0.5 million, respectively.  As of May 31, 2024, there was $2.5 million of unrecognized stock-based compensation cost related to unvested stock options which is expected to be recognized over a weighted average period of 1.7 years.

 

Stock Option Valuation

The fair value of stock options at the date of grant was estimated using the Black Scholes option pricing model. The assumptions that the Company used to determine the grant-date fair value of stock options granted for the six months ended May 31, 2024 were as follows:

 

Risk free rate

 4.10%

Expected dividends

$

Expected volatility

 75.75%

Expected life (in years)

 6.5

Market price of the Company’s common stock on date of grant

$6.89
   

 

The following table summarizes option activity under the 2020 Plan during the six months ended May 31, 2024:

 

        
      

Weighted-Average

 
  

Stock

  

Exercise Price Per Stock

 
  

Options

  

Option

 

Outstanding, November 30, 2023

  1,384,666  $7.12 

Granted

  199,500   6.89 

Exercised

  (244,465)  2.20 

Outstanding, May 31, 2024

  1,339,701  $9.00 

Exercisable, May 31, 2024

  673,602  $9.41 

 

 

Of the 244,465 shares issued upon exercise of options, 37,033 options were used due to cashless exercise.  

 

13

  
 

15.

EARNINGS PER SHARE

 

For the three and six months ended May 31, 2024, the Company recorded net income and, as such, used diluted weighted-average common shares outstanding when calculating diluted income per share for the three and six months ended May 31, 2024. Stock options and RSUs that could potentially dilute basic earnings per share (“EPS”) in the future are included in the computation of diluted income per share.


For the three and six months ended May 31, 2023, the Company recorded net loss available to common shareholders.  As such, because the dilution impact from potential common shares was antidilutive, the Company used basic weighted-average common shares outstanding, rather than diluted weighted-average common shares outstanding when calculating diluted loss per share for the three and six months ended May 31, 2023

 

The following table sets forth the allocation of net income (loss) for the three and six months ended May 31, 2024 and 2023, respectively:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Net income (loss)

 $2,077  $(1,116) $2,094  $(3,269)
                 

Weighted-average number of shares used in computing net income (loss) per share, basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Net income (loss) per share - basic

 $0.09  $(0.05) $0.09  $(0.15)

Weighted-average number of shares used in computing net income (loss) per share, diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

Net income (loss) per share - diluted

 $0.09  $(0.05) $0.09  $(0.15)

 

 

The following table reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the three and six months ended May 31, 2024 and 2023:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Weighted-average common shares outstanding- basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Assumed conversion of:

                

Dilutive stock options

  315,374      117,374    

Dilutive RSUs

  687,202      441,387    

Weighted-average common share outstanding- diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

 

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Options

  36,000   1,514,416   452,166   1,514,416 

RSUs

     1,254,266   224,513   1,254,266 

Total

  36,000   2,768,682   676,679   2,843,682 

 

 

16.

RELATED PARTY TRANSACTIONS 

 

The following transactions are in the normal course of operations and are measured at the amount of consideration established and agreed to by related parties. Amounts due to related parties are unsecured, non-interest bearing and due on demand.

 

The Company terminated the royalty payments to the Company's former CTO in  December 2021 and granted 200,000 RSUs during the fiscal year ended  November 30, 2022 in exchange to waive all future rights and entitlements to the former CTO.  During the fiscal year ended  November 30, 2023, the Company and the former CTO agreed to immediately accelerate the 200,000 RSUs, which resulted in $0.5 million in accelerated stock compensation expense.  

 

The Company subleases office premises at its Massachusetts headquarters to a corporation owned and controlled by the Chief Executive Officer ("CEO") of the Company beginning July 1, 2020, with no stated termination date. Sublease payments received were a nominal amount for the three and six months ended May 31, 2024 and 2023.

 

Fusady is owned, in equal 25% shares, by four individual investors. These four individuals also each own 25% of Bersa S.A. Bersa S.A. is a distributor of the Company’s products in Argentina. There were $0.1 million sales to Bersa S.A. during the three and six months ended May 31, 2024 and less than $0.05 million and $0.1 million for the three and six months ended May 31, 2023. As of May 31, 2024, the Company had accounts receivable of approximately $0 and $1.6 million as of  November 30, 2023.

 

14

 
 

17.

LEASES

 

Operating Leases

The Company has operating leases for real estate in the United States and South Africa and does not have any finance leases.

 

In 2019, the Company entered into a real estate lease for office space in Andover, Massachusetts.  In August 2021, the lease was amended to include additional space and extend the term of the existing space by one year. The new lease expiration date is February 29, 2028.  

 

The Company leases office and warehouse space in South Africa that expires in December 2024. 

 

The Company leases warehouse and manufacturing space in Fort Wayne, Indiana. The lease expires on July 31, 2025. Commencing in August 2022, the Company sub-leased the former Fort Wayne facility.  The amount received from the sub-lease is immaterial.  In March 2024, the Company terminated the lease and sublease on the former Fort Wayne facility. 

 

The Company also leases office space in Las Vegas, Nevada, which expires on January 31, 2027.  

 

Certain of the Company’s leases contain options to renew and extend lease terms and options to terminate leases early. Reflected in the right-of-use asset and lease liability on the Company’s balance sheets are the periods provided by renewal and extension options that the Company is reasonably certain to exercise, as well as the periods provided by termination options that the Company is reasonably certain to not exercise.

 

For the three and six months ended May 31, 2024, the elements of lease expense were as follows (in thousands):

 

  

Three Months Ended

  

Six Months Ended

 
  

May 31, 2024

  

May 31, 2024

 

Lease Cost:

        

Operating lease cost

 $243  $397 
         

Other Information:

        

Cash paid for amounts included in the measurement of operating lease liabilities

 $258  $426 

Operating lease liabilities arising from obtaining right-of-use assets

 $  $ 
         

Operating Leases:

        

Weighted-average remaining lease term (in years)

      3.2 

Weighted-average discount rate

      9.6%

 

Future lease payments under non-cancelable operating leases as of May 31, 2024 are as follows (in thousands):

 

Fiscal Year Ending November 30,

    

2024 (six months)

 $303 

2025

  523 

2026

  527 

2027

  394 

2028

  53 

Total lease payments

  1,800 

Less: imputed interest

  249 

Present value of operating lease liabilities

 $1,551 

Operating lease liabilities, current

 $552 

Operating lease liabilities, non-current

 $999 

 

15

 
 

18.

INCOME TAXES

 

For the three months ended May 31, 2024, the Company recorded a nominal amount of income tax expense. For the three months ended May 31, 2023, the Company recorded an income tax expense of $0.02 million. For the three months ended May 31, 2024 and 2023, the effective tax rate was 0.1% and 1.6%, respectively.   For the six months ended May 31, 2024, the Company recorded a nominal amount of income tax expense. For six months ended May 31, 2023, the Company recorded an income tax benefit of $0.04 million.  For the six months ended May 31, 2024 and 2023, the effective tax rate was 0.2% and (1.3)%, respectively.   The Company’s tax rate differs from the statutory rate of 21.0% due to the effects of state taxes net of federal benefit, the foreign tax rate differential as a result of Byrna South Africa, effects of permanent non-deductible expenses, the recording of a valuation allowance against the deferred tax assets generated in the current period, and other effects.    

 

 

19.

COMMITMENTS AND CONTINGENCIES

 

Royalty Payment

Pursuant to the Purchase and Sale Agreement, dated April 13, 2018, and further amended on December 19, 2019, the Company was committed to a minimum royalty payment of $0.03 million per year.  Royalties on CO2 pistols were to be paid for so long as patents remain effective. Royalties on the fintail projectiles (and any improved versions thereof) will be paid so long as patents remain effective at a rate of 4% of the agreed upon Stipulated Net Price for fintail projectile products.  On  January 7, 2022, the Company and its former CTO agreed to waive all future rights and entitlements under such agreement, including without limitation any right, title, or interest in the intellectual property or royalty fees except for those on the fintail projectiles.  In exchange for the royalty termination, the Company agreed to grant 200,000 RSU's on  August 3, 2022, which then vests in two years from  January 7, 2022.  In  June 2023, the Company and the former CTO agreed to accelerate the vesting of the 200,000 RSUs, and the Company recognized stock compensation expense of $1.0 million associated with the RSUs during the year ended  November 30, 2023.

 

Legal Proceedings

In the ordinary course of our business, the Company may be subject to certain other legal actions and claims, including product liability, consumer, commercial, tax and governmental matters, which may arise from time to time. The Company does not believe it is currently a party to any pending legal proceedings. Notwithstanding, legal proceedings are subject-to inherent uncertainties, and an unfavorable outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse impact on the Company’s business, financial position, results of operations, and/or cash flows. Additionally, although the Company has specific insurance for certain potential risks, the Company may in the future incur judgments or enter into settlements of claims which may have a material adverse impact on the Company’s business, financial position, results of operations, and/or cash flows.

 

 

20.

SEGMENT AND GEOGRAPHICAL DISCLOSURES

 

The CEO, who is also the Chief Operating Decision Maker, evaluates the entire business as a single entity, which includes reviewing financial information and making business decisions based on the overall results of the business. As such, the Company’s operations constitute a single operating segment and one reportable segment. 

 

The tables below summarize the Company’s revenue for the three and six months ended May 31, 2024 and 2023, respectively, by geographic region (in thousands):

 

Revenue:

                    

Three Months Ended

 

U.S./Mexico

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $18,659  $41  $1,015  $554  $20,269 

May 31, 2023

  10,004   178   1,082   244   11,508 

 

Six Months Ended

 

U.S.

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $34,197  $104  $1,532  $1,090  $36,923 

May 31, 2023

  17,996   211   1,207   505   19,919 

 

16

 
 

21.

FINANCIAL INSTRUMENTS

 

The Company is exposed to risks that arise from its use of financial instruments. This note describes the Company’s objectives, policies and processes for managing those risks and the methods used to measure them.

 

 

i)

Currency Risk

The Company held its cash balances within banks in the U.S. in U.S. dollars and with banks in South Africa in U.S. dollars and South African rand. The Company’s operations are conducted in the U.S. and South Africa. The value of the South African rand against the U.S. dollar may fluctuate with changes in economic conditions.

 

During the six months ended May 31, 2024, in comparison to the prior year period, the U.S. dollar on average was stronger in relation to the South African rand, and upon the translation of the Company’s subsidiaries’ revenues, expenses, assets and liabilities held in South African rand.  The Company recorded a translation adjustment gain of $0.03 million and loss of $1.2 million related to the South African rand during the six months ended May 31, 2024 and 2023, respectively.  

 

The Company’s South African subsidiary revenues, cost of goods sold, operating costs and capital expenditures are denominated in South African rand. Consequently, fluctuations in the U.S. dollar exchange rate against the South African rand increases the volatility of sales, cost of goods sold and operating costs and overall net earnings when translated into U.S. dollars. The Company is not using any forward or option contracts to fix the foreign exchange rates. Using a 10% fluctuation in the U.S. exchange rate, the impact on the loss and stockholders’ equity is not material.

 

 

ii)

Credit Risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. The financial instruments that potentially subject the Company to credit risk consist of cash, cash equivalents, accounts receivable, and the loan receivable from Byrna LATAM. The Company maintains cash with high credit quality financial institutions located in the U.S. and South Africa. The Company maintains cash and cash equivalent balances with financial institutions in the U.S. in excess of amounts insured by the Federal Deposit Insurance Corporation.

 

The Company is exposed to credit losses on accounts receivable balances. The Company uses a simplified approach to calculate a general provision for credit losses. An allowance is calculated for each aging “bucket,” based on the risk profile of that bucket. The Company revisits the reserve periodically, but no less than quarterly, with the same analytical approach in order to determine if the allowance needs to be increased or decreased, based calculation of each aging bucket.

 

The Company loaned $1.6 million to Byrna LATAM, which was formed in January 2023 as a joint venture in South America.  The Company determines if an estimate for a credit loss on this loan is needed by considering the financial position of Byrna LATAM, the current economic environment, collections on our accounts receivable balances with Byrna LATAM, as well reasonable and supportable forecasts to support the payment of this loan.  The Company reviews these factors quarterly to determine if any adjustments are needed.  

 

17

 
 

ITEM 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

 

References in this quarterly report on Form 10-Q (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Byrna Technologies Inc. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” "may," “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important risk factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of our Annual Report on Form 10-K for the year ended November 30, 2023 filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 14, 2024, as amended on March 29, 2024 (the “2023 10-K”), and the Company’s subsequent filings with the SEC, all of which can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, including but not limited to our ability to design, introduce and sell new products, services and features, the impact of any regulatory proceedings or litigation, our ability to protect our intellectual property and compete with existing and new products, the impact of stock compensation expense, dividends, warrant exercises and related accounting, impairment expense and income tax expense on our financial results, our ability to manage our supply chain and avoid production delays, shortages or other factors, including product mix, cost of parts and materials and cost of labor that may impact our gross margins, our ability to retain and incentivize key management personnel, product defects, the success of our entry to new markets, customer purchase behavior and negative media publicity or public perception of our brand or products, restrictions or prohibitions imposed by advertising platforms, loss of customer data, breach of security or an extended outage related to our e-commerce storefronts, including a breach or outage by our third party cloud based storage providers, exposure to international operational risks, delayed cash collections or bad debt, determinations or audits by taxing authorities, changes in government regulations, the impact of existing or future regulation by the Bureau of Alcohol, Tobacco, and Firearms, import and export regulators, or other federal or state authority, or changes in international law in key jurisdictions including South America and South Africa or our inability to obtain needed exemptions from such existing or future regulation.

 

OVERVIEW

 

The following discussion and analysis is intended to help you understand us, our operations and our financial performance. It should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes, which are included in Item 1 of this report.

 

Byrna Technologies is a designer, manufacturer, retailer and distributor of innovative technological solutions for security situations that do not require the use of lethal force. Our mantra is Live Safe, and our core mission is to empower individuals to safely and fully engage in life and adventure. Our design team’s directive is to build easy-to-use self-defense tools to enhance the safety of our customers and their loved ones at home and outdoors. We are also focused on developing tools that can be used instead of firearms by professional law enforcement and private security customers to reduce shootings and facilitate trust between police and the communities they seek to serve. Our strategy is to establish Byrna® as a consumer lifestyle brand associated with the confidence people can achieve by knowing they can protect themselves, their loved ones and those around them. We believe we have a significant opportunity to leverage the Byrna brand to expand our product line, broaden our user base and generate increasing sales from new and existing customers.

 

18

 

Our business strategy is twofold: (1) to fulfill the growing demand for less-lethal products in the law enforcement, correctional services, and private security markets and (2) to provide civilians – including those whose work or daily activities may put them at risk of being a victim – with easy access to an effective, non-lethal way to protect themselves and their loved ones from threats to their person or property.

 

We believe that the United States, along with many other parts of the world, is experiencing a significant spike in the demand for less-lethal products and that the less-lethal market will be one of the faster growing segments of the security market over the next decade.  We plan to respond to this demand for less-lethal products through the serial production and distribution of the Byrna® SD and expansion of the Byrna product line.

 

On January 10, 2023, the Company created a new joint venture ("Byrna LATAM") with Fusady S.A. ("Fusady") located in Uruguay, to expand the Company's operations and presence in South American markets.  The Company holds 51% of the stock in Byrna LATAM, and the remaining 49% of stock in Byrna LATAM is held by Fusady. Under the terms of the joint venture, the Company does not control the entity.

 

RESULTS OF OPERATIONS

 

Three months ended May 31, 2024 as compared to three months ended May 31, 2023:

 

Net Revenue

Revenues were $20.3 million in the fiscal quarter of 2024 which represents an increase of $8.8 million as compared to the prior year period revenues of $11.5 million.  Most of the increase in revenue can be attributed to a new marketing strategy, implemented in September of 2023, shifting advertising efforts away from social media platforms and to celebrity endorsers. Direct to customer sales, via Amazon and the Company’s website, increased by $8.0 million from $6.8 million in the fiscal quarter of 2023 to $14.8 million in the fiscal quarter of 2024.  Sales to domestic dealers and retailers also improved, increasing by 24% to $3.8 million from $3.1 million in the three months ended May 31, 2023. Sales to Canadian customers increased by $0.2 million or 65% to $0.6 million as compared to $0.3 million in the three months ended May 31, 2023. Sales to all other international markets decreased slightly from $1.3 million in the three months ended May 31, 2023 to $1.1 million in the three months ended May 31, 2024.

 

Cost of Goods Sold

Cost of goods sold was $7.7 million in the fiscal quarter of 2024 compared to $5.3 million in the prior year period. This $2.4 million increase is due to the increase in sales volumes.

 

Gross Profit

Gross profit is calculated as total revenue less cost of goods sold and gross margin is calculated as gross profit divided by total revenue. Included as cost of goods sold are costs associated with the production and procurement of products, such as labor and overhead, inbound freight costs, manufacturing depreciation, purchasing and receiving costs, and inspection costs. Gross profit was $12.6 million in the fiscal quarter of 2024, or 62.0% of net revenue, as compared to gross profit of approximately $6.2 million, or 53.9% of net revenue, in the prior year period.  The improvement in gross profit as a percentage of sales is primarily due to the increase in the proportion of high margin direct to customer sales, from 62% of total sales in the prior year period to 75% of sales in the fiscal quarter of 2024. The improvement was also due to higher absorption of fixed costs by increased production volume and due to reduced reliance on price discounts for sales promotions.

  

Operating Expenses

Operating expenses were $10.6 million in the fiscal quarter of 2024, an increase of $3.5 million, as compared to the prior year period expenses of $7.2 million.  The increase is due to an increase of $1.9 million in marketing expenses, an increase of $1.1 million in variable expenses, which increase in proportion to sales volume, an increase of $1.1 million in accrued employee compensation costs. These cost increases were offset by a decrease of $0.6 million in stock compensation expense.

  

Other Income (Expense)

The Company recorded $0.2 million of foreign currency translation loss during the three months ended May 31, 2024 compared to $0.05 million of foreign currency translation loss during the three months ended May 31, 2023. The Company recorded $0.3 million of interest income during the three months ended May 31, 2024 compared to $0.1 million in the three months ended May 31, 2023.  The Company recorded a gain of $0.06 million from its South American joint venture investment as compared to a loss of $0.2 million in the three months ended May 31, 2023.  

 

19

 

Income Tax Provision

For the three months ended May 31, 2024 and 2023, the Company recorded a nominal amount and $0.02 million of income tax expense, respectively. For the three months ended May 31, 2024 and 2023, the effective tax rate was 0.1% and 1.6%, respectively.  The Company’s tax rate differs from the statutory rate of 21.0% due to the effects of state taxes net of federal benefit, the foreign tax rate differential as a result of Byrna South Africa, effects of permanent non-deductible expenses, the recording of a valuation allowance against the deferred tax assets generated in the current period, and other effects. 

 

Net Income/(Loss)

Net income was $2.1 million for the three months ended May 31, 2024, an improvement of $3.2 million compared to the net loss of $1.1 million for the three months ended May 31, 2023.

    

Non-GAAP Financial Measures

In addition to providing financial measurements based on generally accepted accounting principles in the United States (GAAP), we provide an additional financial metric that is not prepared in accordance with GAAP (non-GAAP) with presenting non-GAAP adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate our financial performance. We believe that this non-GAAP financial measure helps us to identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we exclude in the calculations of the non-GAAP financial measure.

 

Accordingly, we believe that this non-GAAP financial measure reflects our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business and provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects.

 

This non-GAAP financial measure does not replace the presentation of our GAAP financial results and should only be used as a supplement to, not as a substitute for, our financial results presented in accordance with GAAP. There are limitations in the use of non-GAAP measures, because they do not include all the expenses that must be included under GAAP and because they involve the exercise of judgment concerning exclusions of items from the comparable non-GAAP financial measure. In addition, other companies may use other non-GAAP measures to evaluate their performance, or may calculate non-GAAP measures differently, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison.

 

Adjusted EBITDA

 

Adjusted EBITDA is defined as net (loss) income as reported in our condensed consolidated statements of operations and comprehensive (loss) income excluding the impact of (i) depreciation and amortization; (ii) income tax provision (benefit); (iii) interest income (expense); (iv) stock-based compensation expense, (v) impairment loss and (vi) one-time, non-recurring other expenses or income. Our Adjusted EBITDA measure eliminates potential differences in performance caused by variations in capital structures (affecting finance costs), tax positions, the cost and age of tangible assets (affecting relative depreciation expense) and the extent to which intangible assets are identifiable (affecting relative amortization expense). We also exclude certain one-time and non-cash costs. Reconciliation of Adjusted EBITDA to net (loss) income, the most directly comparable GAAP measure, is as follows (in thousands):

 

   

For the Three Months Ended

 
    May 31,  
   

2024

   

2023

 

Net income (loss)

  $ 2,077     $ (1,116 )
                 

Adjustments:

               

Interest income

    (323 )     (143 )

Income tax expense

    3       17  

Depreciation and amortization

    337       300  

Non-GAAP EBITDA

    2,094       (942 )
                 

Stock-based compensation expense

    858       1,487  

Impairment loss

          176  

Severance/Separation

          52  

Non-GAAP adjusted EBITDA

  $ 2,952     $ 773  

 

20

 

Six months ended May 31, 2024 as compared to six months ended May 31, 2023:

 

Net Revenue

Revenues were $36.9 million in the first half of 2024, an increase of $17.0 million or 85% from revenues of $19.9 in the first half of 2023.  Most of the increase in revenue can be attributed to a new marketing strategy, implemented in September of 2023, shifting advertising efforts away from social media platforms and to celebrity endorsers. Direct to customer sales, via Amazon and the Company’s website, increased by $14.6 million from $13.0 million in the first half of 2023 to $27.5 million in the first half of 2024. Sales to domestic dealers and retailers also improved, increasing by 33% to $6.4 million from $4.8 million in the first half of 2023. Sales to Canadian customers increased by $0.4 million or 49% to $1.1 million as compared to $0.7 million in the first half of 2023. Sales to all other international markets increased from $1.4 million in the first half of 2023 to $1.9 million in the first half of 2024.

 

Cost of Goods Sold

Cost of goods sold was $14.7 million in the first half of 2024 compared to $8.5 million in the prior year period. The increase is due to the increase in sales volume.

 

Gross Profit

Gross profit is calculated as total revenue less cost of goods sold and gross margin is calculated as gross profit divided by total revenue. Included as cost of goods sold are costs associated with the production and procurement of products, such as labor and overhead, inbound freight costs, manufacturing depreciation, purchasing and receiving costs, and inspection costs. Gross profit was $22.2 million in the first half of 2024, or 60.1% of net revenue, as compared to gross profit of approximately $11.4 million, or 57.5% of net revenue, in the prior year period.  The improvement in gross profit as a percentage of sales is primarily due to the increase in the proportion of high margin direct to customer sales, from 68% of total sales in the prior year period to 76% of sales in the first half of 2024. The improvement was also due to higher absorption of fixed costs by increased production volume and due to reduced reliance on price discounts for sales promotions.

 

Operating Expenses

Operating expenses were $20.5 million in the first half of 2024, an increase of $6.0 million, as compared to the prior year period expenses of $14.4 million.  The increase is due to an increase of $3.8 million in marketing expenses, an increase of $1.6 million in variable expenses, which increase in proportion to sales volume, an increase of $1.5 million in employee compensation costs. These cost increases were offset by a decrease of $1.2 million in stock compensation expense.

 

Other Income (Expense)

The Company recorded $0.3 million of foreign currency translation loss during the first half of 2024 compared to $0.2 million of foreign currency translation loss during the first half of 2023. The Company recorded $0.6 million of interest income during the first half of 2024 compared to $0.3 million in the first half of 2023.  The Company recorded a gain of $0.02 million from its South American joint venture investment that was formed during the first half of 2023 as compared to a loss of $0.3 million in the first half of 2023. 

 

 

21

 

Income Tax Provision

For the six months ended May 31, 2024 and 2023, the Company recorded an income tax expense of $0.01 million and income tax benefit of $0.04 million, respectively. For the six months ended May 31, 2024 and 2023, the effective tax rate was 0.2% and (1.3)%, respectively.  The Company’s tax rate differs from the statutory rate of 21.0% due to the effects of state taxes net of federal benefit, the foreign tax rate differential as a result of Byrna South Africa, effects of permanent non-deductible expenses, the recording of a valuation allowance against the deferred tax assets generated in the current period, and other effects.

 

Net Income/(Loss)

Net income was $2.1 million for the first half of 2024, an improvement of $5.4 million compared to the net loss of $3.3 million for the first half of 2023.

    

Non-GAAP Financial Measures

In addition to providing financial measurements based on generally accepted accounting principles in the United States (GAAP), we provide an additional financial metric that is not prepared in accordance with GAAP (non-GAAP) with presenting non-GAAP adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate our financial performance. We believe that this non-GAAP financial measure helps us to identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we exclude in the calculations of the non-GAAP financial measure.

 

Accordingly, we believe that this non-GAAP financial measure reflects our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business and provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects.

 

This non-GAAP financial measure does not replace the presentation of our GAAP financial results and should only be used as a supplement to, not as a substitute for, our financial results presented in accordance with GAAP. There are limitations in the use of non-GAAP measures, because they do not include all the expenses that must be included under GAAP and because they involve the exercise of judgment concerning exclusions of items from the comparable non-GAAP financial measure. In addition, other companies may use other non-GAAP measures to evaluate their performance, or may calculate non-GAAP measures differently, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison.

 

Adjusted EBITDA

 

Adjusted EBITDA is defined as net (loss) income as reported in our condensed consolidated statements of operations and comprehensive (loss) income excluding the impact of (i) depreciation and amortization; (ii) income tax provision (benefit); (iii) interest income (expense); (iv) stock-based compensation expense, (v) impairment loss and (vi) one-time, non-recurring other expenses or income. Our Adjusted EBITDA measure eliminates potential differences in performance caused by variations in capital structures (affecting finance costs), tax positions, the cost and age of tangible assets (affecting relative depreciation expense) and the extent to which intangible assets are identifiable (affecting relative amortization expense). We also exclude certain one-time and non-cash costs. Reconciliation of Adjusted EBITDA to net (loss) income, the most directly comparable GAAP measure, is as follows (in thousands):

 

   

For the Six Months Ended

 
   

May 31,

 
   

2024

   

2023

 

Net income (loss)

  $ 2,094     $ (3,269 )
                 

Adjustments:

               

Interest income

    (604 )     (286 )

Income tax provision (benefit)

    3       (41 )

Depreciation and amortization

    675       582  

Non-GAAP EBITDA

    2,168       (3,014 )
                 

Stock-based compensation expense

    1,796       2,951  

Impairment loss

          176  

Severance/Separation

    175     $ 52  

Non-GAAP adjusted EBITDA

  $ 4,139     $ 165  

 

22

 

LIQUIDITY AND CAPITAL RESOURCES

 

Cash Flow Summary

Cash and cash equivalents as of May 31, 2024 totaled $24.8 million, an increase of $4.3 million from $20.5 million of cash and cash equivalents as of November 30, 2023. 

 

Operating Activities

Cash provided by operating activities was $5.9  million for the six months ended May 31, 2024 compared to cash used in operations of $2.4 million during the prior year period. Net income was $2.1 million compared to net loss of $3.3 million for the six months ended May 31, 2024 and 2023, respectively. Significant changes in noncash and working capital activity are as follows:

 

Non-cash activity includes stock-based compensation expenses of $1.8  million for the six months ended May 31, 2024 compared to $3.0  million for the six months ended May 31, 2023; depreciation and amortization expense of $0.7 million for the six months ended May 31, 2024 compared to $0.6 million for the six months ended May 31, 2023, amortization of right-of-use assets of $0.3 million for the six months ended May 31, 2024 compared to $0.3 million for the six months ended May 31, 2023, and less than a $0.1 million of joint venture investment loss in the six months ended May 31, 2024 compared to $0.4 million during the six months ended May 31, 2023.  

 

Inventory increased during the six months ended May 31, 2024 by $1.6 million compared to increase of $2.7 million for the six months ended May 31, 2023.  Accounts receivable decreased by $1.3  million during the six months ended May 31, 2024 as compared to a decrease of $1.3  million for the six months ended May 31, 2023.  Accounts payable and accrued liabilities increased during the six months ended May 31, 2024 by $3.0  million compared to a decrease of $1.4  million for the six months ended May 31, 2023. Prepaid expenses and other current assets increased by $0.9 million during the six months ended May 31, 2024 compared to an increase of $0.1  million during the six months ended May 31, 2023.  Operating lease liabilities decreased by $0.4 million during the six months ended May 31, 2024 compared to a decrease of $0.4 million during the six months ended May 31, 2023. Deferred revenues decreased $0.5 million during the six months ended May 31, 2024 compared to a decrease of $0.2 million for the six months ended May 31, 2023, respectively.

 

Investing Activities

Cash used in investing activities was $0.7 million for the six months ended May 31, 2024 compared to $2.2 million for the six months ended May 31, 2023. The prior year period investing activities primarily relates to the investment in the joint venture and the corresponding loan while the current period relates to purchases of property and equipment.  

 

Financing Activities

Cash used in financing activities was $0.9 million for the six months ended May 31, 2024 compared to zero for the six months ended May 31, 2023.  The current year amount was primarily composed of stock repurchases of $0.3 million and taxes paid on issuances of restricted stock units of $0.8 million. 

 

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or have reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

23

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

See Note 5, “Recent Accounting Guidance,” in the Notes to unaudited condensed consolidated financial statements included in Item 1 of this report for a discussion of recently issued and adopted accounting standards.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our unaudited condensed consolidated financial statements are based on the selection and application of significant accounting policies, which require management to make significant estimates and assumptions. Our significant accounting policies are outlined in Note 4, “Summary of Significant Accounting Policies,” in the Notes to Consolidated Financial Statements included in Item 8 of the 2023 Form 10-K. During the three and six months ended May 31, 2024, there were no significant changes to our critical accounting policies from those described in our 2023 Form 10-K.

 

 

 

24

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable. 

 

ITEM 4.

CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

The Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of May 31, 2024 pursuant to Rule 13a-15(b) of the Exchange Act. Disclosure controls and procedures are designed to ensure that material information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that material information is accumulated and communicated to the Company’s management, including its CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. The Company’s CEO and CFO concluded that as of May 31, 2024, our disclosure controls and procedures were effective.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes that occurred during the second quarter of 2024 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

25

 

PART II - OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

 

In the normal course of business, the Company occasionally becomes involved in various legal proceedings. The results of any such proceedings cannot be predicted with certainty because such matters are inherently uncertain. Significant damages or penalties may be sought in some matters, and some matters may require years to resolve. In our opinion, at this time, any liability from such proceedings would not have a material adverse effect on the business or financial condition of the Company.

 

ITEM 1A. 

RISK FACTORS

 

Factors that could cause our actual results to differ materially from those in this report include the “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended November 30, 2023, filed with the SEC on February 14, 2024, as amended on March 29, 2024.  There have been no material changes to the risk factors disclosed in our 2023 Form 10-K.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4.

MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 

ITEM 5.

OTHER INFORMATION.

 

Insider Adoption or Termination of Trading Arrangements:

 

During the fiscal quarter ended May 31, 2024 none of our directors or officers informed us of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:

 

Name & Title

Date Adopted

Character of Trading Arrangement(2)

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Duration(3)

Other Material Terms

Date Terminated

Northeast Industrial Partners LLP (1)

April 8, 2024

Rule 10b5-1 Trading Arrangement

Up to 100,000shares to be Sold

December 31, 2024

N/A

N/A

 

 

1.

Bryan Ganz, Chief Executive Officer and a director of the Company is an indirect holder of shares held by Northeast Industrial Partners LLC  (“NEIP” or “Seller”) , disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

 

2.

The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended, and complied with the then applicable requirements of Rule 10b5-1(c) when adopted on April 8, 2024.

 

3.

Except as indicated by footnote and unless terminated or suspended, the Trading Arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table. The Trading Arrangement only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule. The Trading Arrangement also provides for automatic expiration on the date on which the broker receives notice of the death of Seller or of the commencement of any proceedings in respect of or triggered by Seller's bankruptcy or insolvency.

 

Departure and Appointment of Officers

 

On June 24, 2024, the Company announced that David North, its Chief Financial Officer ("CFO"), would retire effective July 15, 2024.  The Company has appointed Lauri Kearnes as CFO, effective July 15, 2024.  Ms. Kearnes is working with the Company to ensure a smooth transition.  Mr. North's decision was not caused by any disagreement with the Company, and the Company and Mr. North have entered into a consulting agreement pursuant to which Mr. North will provide consulting services to the Company following his retirement. 

 

 

26

 
 

ITEM 6.

EXHIBITS.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.

Description of Exhibit

10.1 Offer Letter between Byrna Technologies Inc. and John Brasseur, dated July 13, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 30, 2024).
10.2 Offer Letter between Byrna Technologies Inc. and Lauri Kearnes, dated June 12, 2024 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 24, 2024).
10.3 Separation Agreement between Byrna Technologies Inc. and David North, dated June 19, 2024 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 24, 2024).
10.4 Consulting Agreement between Byrna Technologies Inc. and David North, dated June 19, 2024 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 24, 2024).

31.1*

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

Certification of Principal Financial and Accounting Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

Inline XBRL Instance Document

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*

Inline XBRL Taxonomy Extension Schema Document

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

*

Filed herewith.

**

Furnished.

 

27

 

SIGNATURES

 

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Byrna Technologies Inc.

     

Date: July 9, 2024

 

/s/ Bryan Ganz

 

Name: 

Bryan Ganz

 

Title:

Chief Executive Officer, President and Director

   

(Principal Executive Officer)

     

Date: July 9, 2024

 

/s/ David North

 

Name:

David North

 

Title:

Chief Financial Officer

   

(Principal Financial and Accounting Officer)

 

28

Exhibit 31.1

 

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, Bryan Ganz, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Byrna Technologies Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 9, 2024

By:

/s/ Bryan Ganz

   

Bryan Ganz

   

Chief Executive Officer, President, and Director
(Principal Executive Officer)

 

 

Exhibit 31.2

 

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, David North, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Byrna Technologies Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 9, 2024

By:

/s/ David North

   

David North

   

Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

 

Exhibit 32.1

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Byrna Technologies Inc. (the “Company”) for the period ended May 31, 2024, as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: July 9, 2024

By:

/s/ Bryan Ganz

   

Bryan Ganz

Chief Executive Officer, President, and Director
(Principal Executive Officer)

     
 

By:

/s/ David North

   

David North

Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 
v3.24.2
Document And Entity Information - shares
6 Months Ended
May 31, 2024
Jul. 09, 2024
Document Information [Line Items]    
Entity Central Index Key 0001354866  
Entity Registrant Name Byrna Technologies Inc.  
Amendment Flag false  
Current Fiscal Year End Date --11-30  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2024  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date May 31, 2024  
Document Transition Report false  
Entity File Number 333-132456  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 71-1050654  
Entity Address, Address Line One 100 Burtt Road, Suite 115  
Entity Address, City or Town Andover  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01810  
City Area Code 978  
Local Phone Number 868-5011  
Title of 12(b) Security Common stock, $0.001, par value per share  
Trading Symbol BYRN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   22,776,895
v3.24.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 24,788 $ 20,498
Accounts receivable, net 1,635 2,945
Inventory, net 15,500 13,890
Prepaid expenses and other current assets 1,779 868
Total current assets 43,702 38,201
LONG TERM ASSETS    
Intangible assets, net 3,441 3,583
Deposits for equipment 1,706 1,163
Right-of-use asset, net 1,473 1,805
Property and equipment, net 3,408 3,803
Goodwill 2,265 2,258
Loan to joint venture 1,493 1,473
Other assets 35 28
TOTAL ASSETS 57,523 52,314
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 9,207 6,158
Operating lease liabilities, current 552 644
Deferred revenue, current 1,407 1,844
Total current liabilities 11,166 8,646
LONG TERM LIABILITIES    
Deferred revenue, non-current 45 91
Operating lease liabilities, non-current 999 1,258
Total liabilities 12,210 9,995
COMMITMENTS AND CONTINGENCIES (NOTE 19)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued 0 0
Common stock, $0.001 par value, 50,000,000 shares authorized. 24,964,787 shares issued and 22,776,895 shares outstanding as of May 31, 2024, and 24,168,014 shares issued and 22,002,027 outstanding as of November 30, 2023 24 24
Additional paid-in capital 131,550 130,426
Treasury stock (2,187,892 and 2,165,987 shares purchased as of May 31, 2024 and November 30, 2023, respectively) (17,753) (17,500)
Accumulated deficit (67,481) (69,575)
Accumulated other comprehensive loss (1,027) (1,056)
Total Stockholders’ Equity 45,313 42,319
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 57,523 $ 52,314
v3.24.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
May 31, 2024
Nov. 30, 2023
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 24,964,787 24,168,014
Common stock, shares outstanding (in shares) 22,776,895 22,002,027
Treasury stock, shares (in shares) 2,187,892 2,165,987
v3.24.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Net revenue $ 20,269 $ 11,508 $ 36,923 $ 19,919
Cost of goods sold 7,709 5,309 14,724 8,475
Gross profit 12,560 6,199 22,199 11,444
Operating expenses 10,647 7,191 20,450 14,431
INCOME (LOSS) FROM OPERATIONS 1,913 (992) 1,749 (2,987)
OTHER INCOME (EXPENSE)        
Foreign currency transaction loss (220) (46) (279) (184)
Interest income 323 143 604 286
Income (loss) from joint venture 62 (171) 20 (338)
Other income (expense) 2 (33) 3 (87)
INCOME (LOSS) BEFORE INCOME TAXES 2,080 (1,099) 2,097 (3,310)
Income tax benefit (expense) (3) (17) (3) 41
NET INCOME (LOSS) 2,077 (1,116) 2,094 (3,269)
Foreign currency translation adjustment for the period 144 (641) 29 (1,226)
COMPREHENSIVE INCOME (LOSS) $ 2,221 $ (1,757) $ 2,123 $ (4,495)
Basic net income (loss) per share (in dollars per share) $ 0.09 $ (0.05) $ 0.09 $ (0.15)
Diluted net income (loss) per share (in dollars per share) $ 0.09 $ (0.05) $ 0.09 $ (0.15)
Weighted-average number of common shares outstanding - basic (in shares) 22,728,500 21,866,260 22,383,769 21,863,263
Weighted-average number of common shares outstanding - diluted (in shares) 23,731,076 21,866,260 22,942,530 21,863,263
v3.24.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
May 31, 2024
May 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) for the period $ 2,094 $ (3,269)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Stock-based compensation expense 1,796 2,951
Depreciation and amortization 675 582
Amortization of debt issuance costs 4 0
Amortization of right-of-use asset 332 332
Loss (income) from joint venture (20) 338
Impairment loss 0 176
Changes in assets and liabilities:    
Accounts receivable 1,310 1,258
Deferred revenue (483) (175)
Inventory (1,610) (2,677)
Prepaid expenses and other current assets (910) (77)
Other assets 0 (80)
Accounts payable and accrued liabilities 3,049 (1,369)
Operating lease liabilities (362) (352)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 5,875 (2,362)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (693) (148)
Equity method investment in joint venture 0 (520)
Loan to joint venture 0 (1,556)
NET CASH USED IN INVESTING ACTIVITIES (693) (2,224)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from stock option exercises 128 0
Repurchase of common stock (253) 0
Payment of taxes withheld on issuance of restricted stock units (800) 0
NET CASH USED IN FINANCING ACTIVITIES (925) 0
Effects of foreign currency exchange rate changes 33 (122)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS FOR THE PERIOD 4,290 (4,708)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 20,498 20,068
CASH AND CASH EQUIVALENTS END OF PERIOD $ 24,788 $ 15,360
v3.24.2
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) 24,018,612   (2,165,987)      
Balance (in shares) at Nov. 30, 2022 24,018,612   (2,165,987)      
Balance at Nov. 30, 2022 $ 23 $ 125,474 $ (17,500) $ (61,383) $ (620) $ 45,994
Stock-based compensation $ 0 2,951 $ 0 0 0 2,951
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 13,636   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 0 $ 0 0 0 0
Net income (loss) for the period 0 0 0 (3,269) 0 (3,269)
Foreign currency translation adjustment for the period 0 0 0 0 (1,226) (1,226)
Net Income (Loss) Attributable to Parent 0 0 0 (3,269) 0 (3,269)
Balance at May. 31, 2023 $ 23 128,425 $ (17,500) (64,653) (1,846) 44,449
Balance (in shares) 24,032,248   (2,165,987)      
Balance (in shares) at Feb. 28, 2023 24,032,248   (2,165,987)      
Balance at Feb. 28, 2023 $ 23 126,938 $ (17,500) (63,537) (1,205) 44,719
Stock-based compensation 0 1,487 0 0 0 1,487
Net income (loss) for the period 0 0 0 (1,116) 0 (1,116)
Foreign currency translation adjustment for the period 0 0 0 0 (641) (641)
Net Income (Loss) Attributable to Parent 0 0 0 (1,116) 0 (1,116)
Balance at May. 31, 2023 $ 23 128,425 $ (17,500) (64,653) (1,846) 44,449
Balance (in shares) 24,032,248   (2,165,987)      
Balance (in shares) 24,168,014   (2,165,987)      
Balance (in shares) at Nov. 30, 2023 24,168,014   (2,165,987)      
Balance at Nov. 30, 2023 $ 24 130,426 $ (17,500) (69,575) (1,056) 42,319
Stock-based compensation $ 0 1,796 $ 0 0 0 $ 1,796
Issuance of common stock pursuant to exercise of stock options (in shares) 207,432   0     244,465
Issuance of common stock pursuant to exercise of stock options $ 0 128 $ 0 0 0 $ 128
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 589,341   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 (800) $ 0 0 0 (800)
Repurchase of common stock 0 0 $ (253) 0 0 (253)
Repurchase of common stock (in shares)     (21,905)      
Net income (loss) for the period 0 0 $ 0 2,094 0 2,094
Foreign currency translation adjustment for the period 0 0 0 0 29 29
Net Income (Loss) Attributable to Parent 0 0 0 2,094 0 2,094
Balance at May. 31, 2024 $ 24 131,550 $ (17,753) (67,481) (1,027) 45,313
Balance (in shares) 24,375,754   (2,165,987)      
Balance (in shares) at Feb. 29, 2024 24,375,754   (2,165,987)      
Balance at Feb. 29, 2024 $ 24 131,374 $ (17,500) (69,558) (1,171) 43,169
Stock-based compensation $ 0 858 $ 0 0 0 858
Issuance of common stock pursuant to exercise of stock options (in shares) 39,465   0      
Issuance of common stock pursuant to exercise of stock options $ 0 118 $ 0 0 0 118
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 549,568   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 (800) $ 0 0 0 (800)
Repurchase of common stock 0 0 $ (253) 0 0 (253)
Repurchase of common stock (in shares)     (21,905)      
Net income (loss) for the period 0 0 $ 0 2,077 0 2,077
Foreign currency translation adjustment for the period 0 0 0 0 144 144
Net Income (Loss) Attributable to Parent 0 0 0 2,077 0 2,077
Balance at May. 31, 2024 $ 24 $ 131,550 $ (17,753) $ (67,481) $ (1,027) $ 45,313
Balance (in shares) 24,964,787   (2,187,892)      
v3.24.2
Note 1 - Nature of Operations
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Nature of Operations [Text Block]

1.

NATURE OF OPERATIONS

 

Byrna Technologies Inc. (the “Company” or “Byrna”) is a technology company, specializing in next generation alternatives to traditional firearms without the risk of taking a life.  The Company's launchers can be used for self-defense and personal security by consumers in all 50 states without a firearms license, subject to local regulations. The Company also sells accessories, pepper sprays, and other personal safety tools. Most of the sales are to consumers in the United States via our Company e-commerce site, the Amazon storefront, or the brick and mortar location in Las Vegas, and through retailers, including big box stores.  The Company's products also may be sold to private security and public security officers. Since 2020, the Company has not manufactured or sold any products to or for use by the military. The Company operates two manufacturing facilities, a 30,000 square foot facility located in Fort Wayne, Indiana and a 20,000 square foot manufacturing facility located in Pretoria, South Africa.

 

On January 10, 2023, the Company created a new joint venture ("Byrna LATAM") with Fusady S.A. ("Fusady") located in Uruguay, to expand the Company's operations and presence in South American markets.  The Company holds 51% of the stock in Byrna LATAM, and the remaining 49% of stock in Byrna LATAM is held by Fusady.  See Note 7, "Investment in Joint Venture" for additional information. 

 

v3.24.2
Note 2 - Operations and Management Plans
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Operations and Management Plans Disclosure [Text Block]

2.

OPERATIONS AND MANAGEMENT PLANS

 

From inception to May 31, 2024, the Company has incurred an accumulated deficit of approximately $67.5 million.  The Company has funded operations through the issuance of common stock.  The Company generated net income of $2.1 million for the six months ended May 31, 2024.  The Company’s future success is dependent upon its ability to continue to raise sufficient capital or generate adequate revenues, to cover its ongoing operating expenses, and also to continue to develop and be able to profitably market its products. 

 

Management projects that all cash needs will be met beyond one year from the time these financial statements are issued.

v3.24.2
Note 3 - Basis of Presentation
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Basis of Accounting [Text Block]

3.

BASIS OF PRESENTATION

 

These unaudited condensed consolidated financial statements for the three and six months ended May 31, 2024 and 2023 include the accounts of the Company and its subsidiaries. These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles in the United States of America (“GAAP”); however, such information reflects all adjustments consisting solely of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the results for the interim periods.   All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto together with management’s discussion and analysis of financial condition and results of operations contained in the Company's annual report on Form 10-K for the year ended November 30, 2023. In the opinion of management, the accompanying unaudited condensed consolidated financial statements, the results of its operations for the three and six months ended May 31, 2024 and 2023, and its cash flows for the six months ended May 31, 2024 and 2023 are not necessarily indicative of results to be expected for the full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

 

v3.24.2
Note 4 - Use of Estimates
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Use of Estimates [Text Block]

4.

USE OF ESTIMATES

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Future events and their effects cannot be determined with certainty. Therefore, the determination of estimates requires the exercise of judgment. Actual results could differ from those estimates, and any such differences may be material to our condensed consolidated financial statements. Significant estimates include assumptions about stock-based compensation expense, valuation for deferred tax assets, incremental borrowing rate on leases, valuation and carrying value of goodwill and other identifiable intangible assets, useful life of long-lived assets, inventory reserves, and allowance for credit losses. 

v3.24.2
Note 5 - Recent Accounting Guidance
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Accounting Standards Update and Change in Accounting Principle [Text Block]

5.

RECENT ACCOUNTING GUIDANCE

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs"). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on the financial statements.

 

Recently Adopted Accounting Pronouncement

In 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016- 13”). The guidance changes the impairment model used to measure credit losses for most financial assets. A new forward-looking expected credit loss model will replace the existing incurred credit loss model and will impact the Company’s accounts receivables. This is expected to generally result in earlier recognition of allowances for credit losses. The Company adopted ASU 2016-13 on December 1, 2023, and it did not have a material impact on the Company’s financial statements.

 

Accounting Pronouncement Issued but Not Adopted

In 2023, the FASB issued ASU 2023-09 – Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). This update standardizes categories for the effective tax rate reconciliation, requires disaggregation of income taxes and additional income tax-related disclosures. This update is required to be effective for the Company for fiscal periods beginning after December 15, 2025. The Company is evaluating the effect that ASU 2023-09 will have on its financial statements and disclosures.

 

The FASB also issued ASU 2023-07: Segment Reporting Topic 280 - Improvements to Reportable Segment Disclosures. This update requires expanded annual and interim disclosures for significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. This update will be effective for fiscal years beginning after December 15, 2024, and is to be applied retrospectively to all periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the effect that ASU 2023-07 will have on its financial statements and disclosures and believes it will not have a material impact on the Company’s consolidated financial statements.

 

On March 21, 2024, the FASB issued Accounting Standards Update (ASU) 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards, which provides illustrative guidance to help entities determine whether profits interest and similar awards should be accounted for as share-based payment arrangements within the scope of ASC Topic 718, CompensationStock Compensation.  The Company believes it will not have a material impact on the Company’s consolidated financial statements.

 

 

 

v3.24.2
Note 6 - Goodwill
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Goodwill Disclosure [Text Block]
6.

Goodwill

 

Goodwill resulting from a business combination is not amortized but is reviewed for impairment annually or more frequently when events or changes in circumstances occur that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company has the option to perform a qualitative assessment over goodwill when events occur or circumstances change that would, more likely than not, reduce the fair value of a reporting unit or to bypass the qualitative assessment in any period and proceed directly to performing the quantitative goodwill impairment test. If the Company concludes, based on the qualitative assessment, that the carrying value of a reporting unit would more likely than not exceed its fair value, a quantitative assessment is performed which is based upon a comparison of the reporting unit’s fair value to its carrying value. The fair values used in this evaluation are estimated by the Company based upon future discounted cash flow projections for the reporting unit. An impairment charge is recognized for any amount by which the carrying amount of goodwill exceeds its fair value.

 

The Company performs its annual review for impairment during the third quarter of each year. The Company assesses goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s operations constitute a single reporting unit and goodwill is assessed for impairment at the Company level as a whole. The Company has determined that, as of August 31, 2023, there was no impairment of goodwill, and there have been no events through May 31, 2024 that would indicate that a potential impairment to Goodwill has occurred.

v3.24.2
Note 7 - Investment in Joint Venture
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Equity Method Investments and Joint Ventures Disclosure [Text Block]

7.

 INVESTMENT IN JOINT VENTURE


In January 2023, the Company acquired a 51% ownership interest in Byrna LATAM, a corporate joint venture formed to expand the Company’s operations and presence in South American markets, for $0.5 million. The Company accounts for the investment in the joint venture using the equity method since the Company does not have voting control of Byrna LATAM.  Additionally, the Company does not have substantive participating rights that would result in the Company having control of Byrna LATAM. The Company recorded its share of the joint venture’s income during the three and six months ended May 31, 2024 of less than $0.1 million and losses of $0.2 million and $0.3 million during the three and six months ended May 31, 2023, respectively, in the Consolidated Statements of Operations and Comprehensive Income (Loss) as income (loss) from joint venture. The carrying value of the Company's investment in the joint venture at May 31, 2024 and  November 30, 2023 is at zero in the Consolidated Balance Sheets.

 

In January 2023, the Company loaned $1.6 million to Byrna LATAM.  The loan bears interest at a rate equal to Secured Overnight Financing Rate ("SOFR") plus 3.0%.  The interest rate on the loan was 8.3% as of  May 31, 2024.  The principal amount and accrued interest on the loan amount must be repaid within five years from the date of the loan, or January 10, 2028.  Interest income related to the loan receivable was approximately $0.03 million and $0.06 million for the three and six months ended May 31, 2024, respectively.  The interest income is included in interest income in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).  The loan receivable is recorded as loan to joint venture in the Consolidated Balance Sheets. 

v3.24.2
Note 8 - Advertising Costs
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Advertising Costs [Text Block]

8.

 ADVERTISING COSTS

 

Advertising costs are expenses as incurred and reported in Operating Expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), and include costs of advertising, tradeshows, and other activities designed to enhance demand for the Company's products.  The Company reported advertising costs of approximately $2.5 million and $5.3 million for the three and six months ended May 31, 2024, respectively, $0.6 million and $1.5 million for the three and six months ended May 31, 2023, respectively.

 

v3.24.2
Note 9 - Revenue, Deferred Revenue and Accounts Receivable
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Revenue, Deferred Revenue and Accounts Receivable [Text Block]

9.

REVENUE, DEFERRED REVENUE AND ACCOUNTS RECEIVABLE

 

The Company generates most of its revenue through e-commerce portals to consumers, as well as wholesale distribution of its products and accessories to dealers/distributors and retail stores.  The Company also sells products to large end-users such as private security companies and law enforcement agencies.  The Company does not manufacture or sell any products regulated by the Bureau of Alcohol, Tobacco, Firearms and Explosives or for military applications. Revenue is recognized upon transfer of control of goods to the customer, which generally occurs when title to goods is passed and risk of loss transfers to the customer. Depending on the contract terms, transfer of control is upon shipment of goods to or upon the customer’s pick-up of the goods. Payment terms to customers other than e-commerce customers are generally 30-60 days for established customers, whereas new wholesale and large end-user customers have prepaid terms for their first order. The amount of revenue recognized is net of returns and discounts that the Company offers to its customers. Products purchased include a standard warranty that cannot be purchased separately. This allows customers to return defective products for repair or replacement within one year of sale. The Company also sells an extended warranty for the same terms over three years. The extended 3-year warranty can be purchased separately from the product and is classified as a service warranty. Since a warranty for the first year after sale is included and non-separable from all launcher purchases, the Company considers this extended warranty to represent a service obligation during the second and third years after sale. Therefore, the Company accumulates billings of these transactions on the balance sheet as deferred revenue, to be recognized on a straight-line basis during the second and third year after sale. The Company recognizes an estimated reserve based on its analysis of historical experience, and an evaluation of current market conditions. 

 

The Company offers e-commerce customers a 14-day money-back guarantee, which allows for a full refund of the purchase price, excluding shipping charges, within 14 days from the date of delivery.  The right of return creates a variable component to the transaction price and needs to be considered for any possible constraints. The Company estimates returns using the expected value method, as there will likely be a range of potential return amounts. The Company’s reserve for returns under the 14-day money back guarantee for the three and six months ended May 31, 2024 and 2023 was immaterial.

 

The Company does not offer a money-back guarantee to dealers or retailers. These customers  may request a return or credit for unforeseen reasons or may have agreed discounts or allowances to be netted from amounts invoiced. Accordingly, the Company reserves for returns, discounts and allowances based on past performance and on agreement terms and reports revenue net of the estimated reserve.  The Company's reserve for returns, discounts, and allowances for the three and six months ended May 31, 2024 and 2023 was immaterial.

 

The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs associated with the distribution of finished products to customers, are recorded in operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and are recognized when the product is shipped to the customer.

 

Included as cost of goods sold are costs associated with the production and procurement of products, such as labor and overhead, inbound freight costs, manufacturing depreciation, purchasing and receiving costs, and inspection costs.

 

Accounts Receivable

 

The Company records accounts receivables due from dealers/distributers, large end-users such as retail stores, security companies, and law enforcement agencies.  Accounts receivable, net of allowances, was $1.6 million, $2.9 million and $5.9 million as of  May 31, 2024 November 30, 2023, and  November 30, 2022, respectively.

 

Allowance for Expected Credit Losses

 

The Company estimates the balance of its allowance for expected credit losses. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status and makes judgments about the creditworthiness of customers based on ongoing credit evaluations. The Company also considers customer-specific information, current market conditions, and reasonable and supportable forecasts of future economic conditions. Account balances are written off against the allowance when it is determined that the receivable will not be recovered.  As of May 31, 2024 November 30, 2023, and November 30, 2022, the total allowance for credit losses recorded was $0.3 million, $0.5 million and less than $0.02 million, respectively.  

 

Deferred Revenue

 

The balance of deferred revenue, which relate to unfulfilled e-commerce orders and amounts to be recognized under extended 3-year service warranty, as of  May 31, 2024 and  May 31, 2023 was $1.5 million and $0.6 million, respectively, and $1.9 million and $0.8 million as of  November 30, 2023 and 2022, respectively.  The Company recognized warranty revenue totaling $0.1 million and $0.2 million, respectively, during the three and six months ended  May 31, 2024 and $0.08 million and $0.1 million, respectively, during the three and six months ended  May 31, 2023.  

 

Revenue Disaggregation

 

The following table presents disaggregation of the Company’s revenue by distribution channel (in thousands):

 

  

Three Months Ended

  

Six Months Ended

 
  May 31,  May 31, 

Distribution channel

 

2024

  

2023

  

2024

  

2023

 

Wholesale (dealer/distributors)

 $5,177  $4,669  $8,731  $6,968 

E-commerce (direct to consumers)

  15,092   6,839   28,192   12,951 

Total

 $20,269  $11,508  $36,923  $19,919 
   
v3.24.2
Note 10 - Inventory
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Inventory Disclosure [Text Block]

10.

INVENTORY

 

The following table summarizes inventory (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Raw materials

 $9,645  $7,543 

Work in process

  2,122   2,439 

Finished goods

  3,733   3,908 

Total

 $15,500  $13,890 

 

 

 

 

v3.24.2
Note 11 - Property and Equipment
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]

11.

PROPERTY AND EQUIPMENT

 

The following table summarizes cost and accumulated depreciation (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Computer equipment and software

 $814  $817 

Furniture and fixtures

  274   273 

Leasehold improvements

  990   989 

Machinery and equipment

  3,567   3,425 
   5,645   5,504 

Less: accumulated depreciation

  2,237   1,701 

Total

 $3,408  $3,803 

 

The Company recognized $0.5 million and $0.4 million in depreciation expense during the six months ended May 31, 2024 and 2023, respectively.  The Company recognized $0.3 million and $0.2 million in depreciation expense during the three months ended May 31, 2024 and 2023, respectively.  Depreciation expense is presented in the operating expenses and within cost of goods sold in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

At May 31, 2024 and November 30, 2023, the Company had deposits of $1.7   million and $1.2  million, respectively, with vendors primarily for supply of machinery (molds) and equipment where the vendors have not completed the supply of these assets and is presented as Deposits for equipment in the Condensed Consolidated Balance Sheets.

 

 

 

v3.24.2
Note 12 - Intangible Assets
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

12.

INTANGIBLE ASSETS

 

The components of intangible assets were as follows (in thousands):

 

     

Balance at May 31, 2024

  

Balance at November 30, 2023

 
  

Estimated Useful Lives in Years

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Patents

 

10-17

  $3,931  $(850) $3,081  $3,931  $(723) $3,208 

Trademarks

 

Indefinite

   360      360   360      360 

Customer List

 

2

   70   (70)     70   (55)  15 

Total

    $4,361  $(920) $3,441  $4,361  $(778) $3,583 

 

The trademarks have an indefinite life and will be assessed annually for impairment.  All other intangible assets are finite-lived.

 

Intangible assets amortization expenses are recorded within operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).  Total intangible assets amortization expense for the six months ended May 31, 2024 and 2023 were $0.1  million.  Total intangible assets amortization expense for the three months ended May 31, 2024 and 2023 were less than $0.1  million. 

 

Estimated future amortization expense related to intangible assets as of May 31, 2024 are as follows (in thousands):

 

Fiscal Year Ending November 30,

    

2024 (remaining six months)

 $128 

2025

  254 

2026

  254 

2027

  254 

2028

  254 

Thereafter

  1,937 

Total

 $3,081 

 

v3.24.2
Note 13 - Accounts Payable and Accrued Liabilities
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

13.

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following (in thousands):

 

  

May 31,

  

November 30,

 
  

2024

  

2023

 

Trade payables

 $6,450  $2,617 

Accrued sales and use tax

  362   834 

Accrued people costs

  1,763   2,173 

Accrued professional fees

  148   201 

Other accrued liabilities

  484   333 

Total

 $9,207  $6,158 

 

v3.24.2
Note 14 - Stock-based Compensation
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

14.

STOCK-BASED COMPENSATION

 

2020 Plan

On October 23, 2020, the Company's Board of Directors approved and on November 19, 2020, the stockholders approved the Byrna Technologies Inc. 2020 Equity Incentive Plan (the “2020 Plan”). The aggregate number of shares of common stock available for issuance in connection with options and other awards granted under the 2020 Plan is 3,800,000 shares. The 2020 Plan is administered by the Compensation Committee of the Board. The Compensation Committee determines the persons to whom options to purchase shares of common stock, stock appreciation rights (“SARs”), restricted stock units (“RSUs”), and restricted or unrestricted shares of common stock may be granted. Persons eligible to receive awards under the 2020 Plan are employees, officers, directors, consultants, advisors and other individual service providers of the Company. Awards are at the discretion of the Compensation Committee.

 

The Company accounts for all stock-based payment awards granted to employees and non-employees as stock-based compensation expense at their grant date fair value. The Company’s stock-based payments include stock options, RSUs, and incentive warrants. The measurement date for employee awards is the date of grant, and stock-based compensation costs are recognized as expense over the employees’ requisite service period, on a straight-line basis. The measurement date for non-employee awards is generally the date the services were completed, resulting in financial reporting period adjustments to stock-based compensation during either the expected term or the contractual term. Stock-based compensation costs for non-employees are recognized as expense over the vesting period on a straight-line basis. Forfeitures are accounted for as they occur.

 

The fair value of each grant is estimated on the date of grant by using either the Black-Scholes, Binomial Lattice, or the quoted stock price on the date of grant, unless the awards are subject to market conditions in which case the Company uses the Monte Carlo simulation model. Due to the Company’s limited history, the expected term of the Company’s stock options granted to employees has been determined utilizing the method as prescribed by the SEC’s Staff Accounting Bulletin, Topic 14. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future.

 

Stock-Based Compensation Expense

Stock-based compensation costs are recognized as expense over the employee's requisite service period, on a straight-line basis.  Total stock-based compensation expense was $1.8 million and $3.0 million for the six months ended May 31, 2024 and 2023, respectively.  Total stock-based compensation expense was $0.9 million and $1.5 million for the three months ended May 31, 2024 and 2023, respectively.  Total stock-based compensation expense was recorded in Operating expenses in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

Restricted Stock Units

 

During the six months ended May 31, 2024 the Company granted 600,000 of the RSU's with a “double trigger” for vesting based on stock price and time, as follows: (1) one-third of the RSUs will be triggered when the Company’s stock trades above $6.00 on a 20-day VWAP, the second one-third of the RSUs will be triggered when the Company’s stock trades above $9.00 on a 20-day VWAP, and the final one-third of the RSUs will be triggered when the stock trades above $12.00 on a 20-day VWAP and (2) the employee must remain employed by the Company for three years from the effective date for the RSUs to vest. During the six months ended May 31, 2023, the Company did not grant "double trigger" RSUs.  In addition, the Company also granted 81,656 and 9,805 time-based RSU's during the six months ended May 31, 2024 and 2023, respectively.  Stock-based compensation expense for the RSUs for the six months ended May 31, 2024 and 2023 was $0.9 million and $2.0 million, respectively, and for the three months ended May 31, 2024 and 2023 was $0.4 million and $1.0 million, respectively.

 

The assumptions that the Company used in a Monte Carlo simulation model to determine the grant-date fair value of RSU's granted with a double trigger for the six months ended May 31, 2024 were as follows:

 

Risk free rate

  4.33%

Expected dividends

 $ 

Expected volatility

  33%

Expected life (in years)

  2.7 

Market price of the Company’s common stock on date of grant

 $6.03 
 

As of  May 31, 2024, there was $1.9 million of unrecognized stock-based compensation cost related to unvested RSUs which is expected to be recognized over a weighted average of 2.0 years. 

 

The following table summarizes the RSU activity during the six months ended May 31, 2024:

 

  

RSUs

 

Unvested and outstanding as of November 30, 2023

  976,226 

Granted

  634,513 

Settled

  (658,281)

Forfeited

  (75,250)

Unvested and outstanding at May 31, 2024

  877,208 

 

Of the 658,281 restricted units issued, 68,940 units were returned to the Company in exchange for the Company paying for the payroll withholding taxes.  For the six months ended May 31, 2024, RSUs of 589,341, net, were issued.

 

Stock Options

The Company recorded stock-based compensation expense for options granted to its employees and directors of $0.9 million and $0.9 million during the six months ended May 31, 2024 and 2023, respectively, and for the three months ended May 31, 2024 and 2023 was $0.5 million and $0.5 million, respectively.  As of May 31, 2024, there was $2.5 million of unrecognized stock-based compensation cost related to unvested stock options which is expected to be recognized over a weighted average period of 1.7 years.

 

Stock Option Valuation

The fair value of stock options at the date of grant was estimated using the Black Scholes option pricing model. The assumptions that the Company used to determine the grant-date fair value of stock options granted for the six months ended May 31, 2024 were as follows:

 

Risk free rate

 4.10%

Expected dividends

$

Expected volatility

 75.75%

Expected life (in years)

 6.5

Market price of the Company’s common stock on date of grant

$6.89
   

 

The following table summarizes option activity under the 2020 Plan during the six months ended May 31, 2024:

 

        
      

Weighted-Average

 
  

Stock

  

Exercise Price Per Stock

 
  

Options

  

Option

 

Outstanding, November 30, 2023

  1,384,666  $7.12 

Granted

  199,500   6.89 

Exercised

  (244,465)  2.20 

Outstanding, May 31, 2024

  1,339,701  $9.00 

Exercisable, May 31, 2024

  673,602  $9.41 

 

 

Of the 244,465 shares issued upon exercise of options, 37,033 options were used due to cashless exercise.  

 

v3.24.2
Note 15 - Earnings Per Share
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

15.

EARNINGS PER SHARE

 

For the three and six months ended May 31, 2024, the Company recorded net income and, as such, used diluted weighted-average common shares outstanding when calculating diluted income per share for the three and six months ended May 31, 2024. Stock options and RSUs that could potentially dilute basic earnings per share (“EPS”) in the future are included in the computation of diluted income per share.


For the three and six months ended May 31, 2023, the Company recorded net loss available to common shareholders.  As such, because the dilution impact from potential common shares was antidilutive, the Company used basic weighted-average common shares outstanding, rather than diluted weighted-average common shares outstanding when calculating diluted loss per share for the three and six months ended May 31, 2023

 

The following table sets forth the allocation of net income (loss) for the three and six months ended May 31, 2024 and 2023, respectively:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Net income (loss)

 $2,077  $(1,116) $2,094  $(3,269)
                 

Weighted-average number of shares used in computing net income (loss) per share, basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Net income (loss) per share - basic

 $0.09  $(0.05) $0.09  $(0.15)

Weighted-average number of shares used in computing net income (loss) per share, diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

Net income (loss) per share - diluted

 $0.09  $(0.05) $0.09  $(0.15)

 

 

The following table reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the three and six months ended May 31, 2024 and 2023:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Weighted-average common shares outstanding- basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Assumed conversion of:

                

Dilutive stock options

  315,374      117,374    

Dilutive RSUs

  687,202      441,387    

Weighted-average common share outstanding- diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

 

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Options

  36,000   1,514,416   452,166   1,514,416 

RSUs

     1,254,266   224,513   1,254,266 

Total

  36,000   2,768,682   676,679   2,843,682 

 

v3.24.2
Note 16 - Related Party Transactions
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

16.

RELATED PARTY TRANSACTIONS 

 

The following transactions are in the normal course of operations and are measured at the amount of consideration established and agreed to by related parties. Amounts due to related parties are unsecured, non-interest bearing and due on demand.

 

The Company terminated the royalty payments to the Company's former CTO in  December 2021 and granted 200,000 RSUs during the fiscal year ended  November 30, 2022 in exchange to waive all future rights and entitlements to the former CTO.  During the fiscal year ended  November 30, 2023, the Company and the former CTO agreed to immediately accelerate the 200,000 RSUs, which resulted in $0.5 million in accelerated stock compensation expense.  

 

The Company subleases office premises at its Massachusetts headquarters to a corporation owned and controlled by the Chief Executive Officer ("CEO") of the Company beginning July 1, 2020, with no stated termination date. Sublease payments received were a nominal amount for the three and six months ended May 31, 2024 and 2023.

 

Fusady is owned, in equal 25% shares, by four individual investors. These four individuals also each own 25% of Bersa S.A. Bersa S.A. is a distributor of the Company’s products in Argentina. There were $0.1 million sales to Bersa S.A. during the three and six months ended May 31, 2024 and less than $0.05 million and $0.1 million for the three and six months ended May 31, 2023. As of May 31, 2024, the Company had accounts receivable of approximately $0 and $1.6 million as of  November 30, 2023.

 

v3.24.2
Note 17 - Leases
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

17.

LEASES

 

Operating Leases

The Company has operating leases for real estate in the United States and South Africa and does not have any finance leases.

 

In 2019, the Company entered into a real estate lease for office space in Andover, Massachusetts.  In August 2021, the lease was amended to include additional space and extend the term of the existing space by one year. The new lease expiration date is February 29, 2028.  

 

The Company leases office and warehouse space in South Africa that expires in December 2024. 

 

The Company leases warehouse and manufacturing space in Fort Wayne, Indiana. The lease expires on July 31, 2025. Commencing in August 2022, the Company sub-leased the former Fort Wayne facility.  The amount received from the sub-lease is immaterial.  In March 2024, the Company terminated the lease and sublease on the former Fort Wayne facility. 

 

The Company also leases office space in Las Vegas, Nevada, which expires on January 31, 2027.  

 

Certain of the Company’s leases contain options to renew and extend lease terms and options to terminate leases early. Reflected in the right-of-use asset and lease liability on the Company’s balance sheets are the periods provided by renewal and extension options that the Company is reasonably certain to exercise, as well as the periods provided by termination options that the Company is reasonably certain to not exercise.

 

For the three and six months ended May 31, 2024, the elements of lease expense were as follows (in thousands):

 

  

Three Months Ended

  

Six Months Ended

 
  

May 31, 2024

  

May 31, 2024

 

Lease Cost:

        

Operating lease cost

 $243  $397 
         

Other Information:

        

Cash paid for amounts included in the measurement of operating lease liabilities

 $258  $426 

Operating lease liabilities arising from obtaining right-of-use assets

 $  $ 
         

Operating Leases:

        

Weighted-average remaining lease term (in years)

      3.2 

Weighted-average discount rate

      9.6%

 

Future lease payments under non-cancelable operating leases as of May 31, 2024 are as follows (in thousands):

 

Fiscal Year Ending November 30,

    

2024 (six months)

 $303 

2025

  523 

2026

  527 

2027

  394 

2028

  53 

Total lease payments

  1,800 

Less: imputed interest

  249 

Present value of operating lease liabilities

 $1,551 

Operating lease liabilities, current

 $552 

Operating lease liabilities, non-current

 $999 

 

v3.24.2
Note 18 - Income Taxes
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

18.

INCOME TAXES

 

For the three months ended May 31, 2024, the Company recorded a nominal amount of income tax expense. For the three months ended May 31, 2023, the Company recorded an income tax expense of $0.02 million. For the three months ended May 31, 2024 and 2023, the effective tax rate was 0.1% and 1.6%, respectively.   For the six months ended May 31, 2024, the Company recorded a nominal amount of income tax expense. For six months ended May 31, 2023, the Company recorded an income tax benefit of $0.04 million.  For the six months ended May 31, 2024 and 2023, the effective tax rate was 0.2% and (1.3)%, respectively.   The Company’s tax rate differs from the statutory rate of 21.0% due to the effects of state taxes net of federal benefit, the foreign tax rate differential as a result of Byrna South Africa, effects of permanent non-deductible expenses, the recording of a valuation allowance against the deferred tax assets generated in the current period, and other effects.    

 

v3.24.2
Note 19 - Commitments and Contingencies
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Commitments Disclosure [Text Block]

19.

COMMITMENTS AND CONTINGENCIES

 

Royalty Payment

Pursuant to the Purchase and Sale Agreement, dated April 13, 2018, and further amended on December 19, 2019, the Company was committed to a minimum royalty payment of $0.03 million per year.  Royalties on CO2 pistols were to be paid for so long as patents remain effective. Royalties on the fintail projectiles (and any improved versions thereof) will be paid so long as patents remain effective at a rate of 4% of the agreed upon Stipulated Net Price for fintail projectile products.  On  January 7, 2022, the Company and its former CTO agreed to waive all future rights and entitlements under such agreement, including without limitation any right, title, or interest in the intellectual property or royalty fees except for those on the fintail projectiles.  In exchange for the royalty termination, the Company agreed to grant 200,000 RSU's on  August 3, 2022, which then vests in two years from  January 7, 2022.  In  June 2023, the Company and the former CTO agreed to accelerate the vesting of the 200,000 RSUs, and the Company recognized stock compensation expense of $1.0 million associated with the RSUs during the year ended  November 30, 2023.

 

Legal Proceedings

In the ordinary course of our business, the Company may be subject to certain other legal actions and claims, including product liability, consumer, commercial, tax and governmental matters, which may arise from time to time. The Company does not believe it is currently a party to any pending legal proceedings. Notwithstanding, legal proceedings are subject-to inherent uncertainties, and an unfavorable outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse impact on the Company’s business, financial position, results of operations, and/or cash flows. Additionally, although the Company has specific insurance for certain potential risks, the Company may in the future incur judgments or enter into settlements of claims which may have a material adverse impact on the Company’s business, financial position, results of operations, and/or cash flows.

 

v3.24.2
Note 20 - Segment and Geographical Disclosures
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

20.

SEGMENT AND GEOGRAPHICAL DISCLOSURES

 

The CEO, who is also the Chief Operating Decision Maker, evaluates the entire business as a single entity, which includes reviewing financial information and making business decisions based on the overall results of the business. As such, the Company’s operations constitute a single operating segment and one reportable segment. 

 

The tables below summarize the Company’s revenue for the three and six months ended May 31, 2024 and 2023, respectively, by geographic region (in thousands):

 

Revenue:

                    

Three Months Ended

 

U.S./Mexico

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $18,659  $41  $1,015  $554  $20,269 

May 31, 2023

  10,004   178   1,082   244   11,508 

 

Six Months Ended

 

U.S.

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $34,197  $104  $1,532  $1,090  $36,923 

May 31, 2023

  17,996   211   1,207   505   19,919 

 

v3.24.2
Note 21 - Financial Instruments
6 Months Ended
May 31, 2024
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]

21.

FINANCIAL INSTRUMENTS

 

The Company is exposed to risks that arise from its use of financial instruments. This note describes the Company’s objectives, policies and processes for managing those risks and the methods used to measure them.

 

 

i)

Currency Risk

The Company held its cash balances within banks in the U.S. in U.S. dollars and with banks in South Africa in U.S. dollars and South African rand. The Company’s operations are conducted in the U.S. and South Africa. The value of the South African rand against the U.S. dollar may fluctuate with changes in economic conditions.

 

During the six months ended May 31, 2024, in comparison to the prior year period, the U.S. dollar on average was stronger in relation to the South African rand, and upon the translation of the Company’s subsidiaries’ revenues, expenses, assets and liabilities held in South African rand.  The Company recorded a translation adjustment gain of $0.03 million and loss of $1.2 million related to the South African rand during the six months ended May 31, 2024 and 2023, respectively.  

 

The Company’s South African subsidiary revenues, cost of goods sold, operating costs and capital expenditures are denominated in South African rand. Consequently, fluctuations in the U.S. dollar exchange rate against the South African rand increases the volatility of sales, cost of goods sold and operating costs and overall net earnings when translated into U.S. dollars. The Company is not using any forward or option contracts to fix the foreign exchange rates. Using a 10% fluctuation in the U.S. exchange rate, the impact on the loss and stockholders’ equity is not material.

 

 

ii)

Credit Risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. The financial instruments that potentially subject the Company to credit risk consist of cash, cash equivalents, accounts receivable, and the loan receivable from Byrna LATAM. The Company maintains cash with high credit quality financial institutions located in the U.S. and South Africa. The Company maintains cash and cash equivalent balances with financial institutions in the U.S. in excess of amounts insured by the Federal Deposit Insurance Corporation.

 

The Company is exposed to credit losses on accounts receivable balances. The Company uses a simplified approach to calculate a general provision for credit losses. An allowance is calculated for each aging “bucket,” based on the risk profile of that bucket. The Company revisits the reserve periodically, but no less than quarterly, with the same analytical approach in order to determine if the allowance needs to be increased or decreased, based calculation of each aging bucket.

 

The Company loaned $1.6 million to Byrna LATAM, which was formed in January 2023 as a joint venture in South America.  The Company determines if an estimate for a credit loss on this loan is needed by considering the financial position of Byrna LATAM, the current economic environment, collections on our accounts receivable balances with Byrna LATAM, as well reasonable and supportable forecasts to support the payment of this loan.  The Company reviews these factors quarterly to determine if any adjustments are needed.  

 

v3.24.2
Insider Trading Arrangements
3 Months Ended 6 Months Ended
May 31, 2024
shares
May 31, 2024
shares
Insider Trading Arr Line Items    
Material Terms of Trading Arrangement [Text Block]  

ITEM 5.

OTHER INFORMATION.

 

Insider Adoption or Termination of Trading Arrangements:

 

During the fiscal quarter ended May 31, 2024 none of our directors or officers informed us of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:

 

Name & Title

Date Adopted

Character of Trading Arrangement(2)

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Duration(3)

Other Material Terms

Date Terminated

Northeast Industrial Partners LLP (1)

April 8, 2024

Rule 10b5-1 Trading Arrangement

Up to 100,000shares to be Sold

December 31, 2024

N/A

N/A

 

 

1.

Bryan Ganz, Chief Executive Officer and a director of the Company is an indirect holder of shares held by Northeast Industrial Partners LLC  (“NEIP” or “Seller”) , disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

 

2.

The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended, and complied with the then applicable requirements of Rule 10b5-1(c) when adopted on April 8, 2024.

 

3.

Except as indicated by footnote and unless terminated or suspended, the Trading Arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table. The Trading Arrangement only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule. The Trading Arrangement also provides for automatic expiration on the date on which the broker receives notice of the death of Seller or of the commencement of any proceedings in respect of or triggered by Seller's bankruptcy or insolvency.

 

Departure and Appointment of Officers

 

On June 24, 2024, the Company announced that David North, its Chief Financial Officer ("CFO"), would retire effective July 15, 2024.  The Company has appointed Lauri Kearnes as CFO, effective July 15, 2024.  Ms. Kearnes is working with the Company to ensure a smooth transition.  Mr. North's decision was not caused by any disagreement with the Company, and the Company and Mr. North have entered into a consulting agreement pursuant to which Mr. North will provide consulting services to the Company following his retirement. 

 

 

Non-Rule 10b5-1 Arrangement Adopted [Flag] false  
Non-Rule 10b5-1 Arrangement Terminated [Flag] false  
Rule 10b5-1 Arrangement Terminated [Flag] false  
Rule 10b5-1 Arrangement Adopted [Flag] true  
Trading Arrangement Adoption Date April 8, 2024  
Trading Arrangement, Securities Aggregate Available Amount 100,000 100,000
Trading Arrangement Expiration Date December 31, 2024  
Trading Arrangement, Individual Name Bryan Ganz  
Trading Arrangement, Individual Title Chief Executive Officer  
v3.24.2
Note 9 - Revenue, Deferred Revenue and Accounts Receivable (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

Three Months Ended

  

Six Months Ended

 
  May 31,  May 31, 

Distribution channel

 

2024

  

2023

  

2024

  

2023

 

Wholesale (dealer/distributors)

 $5,177  $4,669  $8,731  $6,968 

E-commerce (direct to consumers)

  15,092   6,839   28,192   12,951 

Total

 $20,269  $11,508  $36,923  $19,919 
v3.24.2
Note 10 - Inventory (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
  

May 31,

  

November 30,

 
  

2024

  

2023

 

Raw materials

 $9,645  $7,543 

Work in process

  2,122   2,439 

Finished goods

  3,733   3,908 

Total

 $15,500  $13,890 
v3.24.2
Note 11 - Property and Equipment (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Property, Plant and Equipment [Table Text Block]
  

May 31,

  

November 30,

 
  

2024

  

2023

 

Computer equipment and software

 $814  $817 

Furniture and fixtures

  274   273 

Leasehold improvements

  990   989 

Machinery and equipment

  3,567   3,425 
   5,645   5,504 

Less: accumulated depreciation

  2,237   1,701 

Total

 $3,408  $3,803 
v3.24.2
Note 12 - Intangible Assets (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Intangible Assets and Goodwill [Table Text Block]
     

Balance at May 31, 2024

  

Balance at November 30, 2023

 
  

Estimated Useful Lives in Years

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Patents

 

10-17

  $3,931  $(850) $3,081  $3,931  $(723) $3,208 

Trademarks

 

Indefinite

   360      360   360      360 

Customer List

 

2

   70   (70)     70   (55)  15 

Total

    $4,361  $(920) $3,441  $4,361  $(778) $3,583 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year Ending November 30,

    

2024 (remaining six months)

 $128 

2025

  254 

2026

  254 

2027

  254 

2028

  254 

Thereafter

  1,937 

Total

 $3,081 
v3.24.2
Note 13 - Accounts Payable and Accrued Liabilities (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
  

May 31,

  

November 30,

 
  

2024

  

2023

 

Trade payables

 $6,450  $2,617 

Accrued sales and use tax

  362   834 

Accrued people costs

  1,763   2,173 

Accrued professional fees

  148   201 

Other accrued liabilities

  484   333 

Total

 $9,207  $6,158 
v3.24.2
Note 14 - Stock-based Compensation (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Risk free rate

  4.33%

Expected dividends

 $ 

Expected volatility

  33%

Expected life (in years)

  2.7 

Market price of the Company’s common stock on date of grant

 $6.03 

Risk free rate

 4.10%

Expected dividends

$

Expected volatility

 75.75%

Expected life (in years)

 6.5

Market price of the Company’s common stock on date of grant

$6.89
   
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
  

RSUs

 

Unvested and outstanding as of November 30, 2023

  976,226 

Granted

  634,513 

Settled

  (658,281)

Forfeited

  (75,250)

Unvested and outstanding at May 31, 2024

  877,208 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
        
      

Weighted-Average

 
  

Stock

  

Exercise Price Per Stock

 
  

Options

  

Option

 

Outstanding, November 30, 2023

  1,384,666  $7.12 

Granted

  199,500   6.89 

Exercised

  (244,465)  2.20 

Outstanding, May 31, 2024

  1,339,701  $9.00 

Exercisable, May 31, 2024

  673,602  $9.41 
v3.24.2
Note 15 - Earnings Per Share (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]
  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Net income (loss)

 $2,077  $(1,116) $2,094  $(3,269)
                 

Weighted-average number of shares used in computing net income (loss) per share, basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Net income (loss) per share - basic

 $0.09  $(0.05) $0.09  $(0.15)

Weighted-average number of shares used in computing net income (loss) per share, diluted

  23,731,076   21,866,260   22,942,530   21,863,263 

Net income (loss) per share - diluted

 $0.09  $(0.05) $0.09  $(0.15)
Schedule of Weighted Average Number of Shares [Table Text Block]
  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Weighted-average common shares outstanding- basic

  22,728,500   21,866,260   22,383,769   21,863,263 

Assumed conversion of:

                

Dilutive stock options

  315,374      117,374    

Dilutive RSUs

  687,202      441,387    

Weighted-average common share outstanding- diluted

  23,731,076   21,866,260   22,942,530   21,863,263 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
  

For the Three Months Ended

  

For the Six Months Ended

 
  May 31,  May 31, 
  

2024

  

2023

  

2024

  

2023

 

Options

  36,000   1,514,416   452,166   1,514,416 

RSUs

     1,254,266   224,513   1,254,266 

Total

  36,000   2,768,682   676,679   2,843,682 
v3.24.2
Note 17 - Leases (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Lease, Cost [Table Text Block]
  

Three Months Ended

  

Six Months Ended

 
  

May 31, 2024

  

May 31, 2024

 

Lease Cost:

        

Operating lease cost

 $243  $397 
         

Other Information:

        

Cash paid for amounts included in the measurement of operating lease liabilities

 $258  $426 

Operating lease liabilities arising from obtaining right-of-use assets

 $  $ 
         

Operating Leases:

        

Weighted-average remaining lease term (in years)

      3.2 

Weighted-average discount rate

      9.6%
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

Fiscal Year Ending November 30,

    

2024 (six months)

 $303 

2025

  523 

2026

  527 

2027

  394 

2028

  53 

Total lease payments

  1,800 

Less: imputed interest

  249 

Present value of operating lease liabilities

 $1,551 

Operating lease liabilities, current

 $552 

Operating lease liabilities, non-current

 $999 
v3.24.2
Note 20 - Segment and Geographical Disclosures (Tables)
6 Months Ended
May 31, 2024
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

Revenue:

                    

Three Months Ended

 

U.S./Mexico

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $18,659  $41  $1,015  $554  $20,269 

May 31, 2023

  10,004   178   1,082   244   11,508 

Six Months Ended

 

U.S.

  

South Africa

  

Europe/South America/Asia

  

Canada

  

Total

 

May 31, 2024

 $34,197  $104  $1,532  $1,090  $36,923 

May 31, 2023

  17,996   211   1,207   505   19,919 
v3.24.2
Note 1 - Nature of Operations (Details Textual)
May 31, 2024
ft²
Jan. 10, 2023
Number of Facilities 2  
Byrna LATAM [Member]    
Equity Method Investment, Ownership Percentage   51.00%
Byrna LATAM [Member] | Fusady [Member]    
Equity Method Investment, Ownership Percentage   49.00%
Fort Wayne, Indiana [Member]    
Area of Real Estate Property (Square Foot) 30,000  
Pretoria South Africa [Member]    
Area of Real Estate Property (Square Foot) 20,000  
v3.24.2
Note 2 - Operations and Management Plans (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Nov. 30, 2023
Retained Earnings (Accumulated Deficit) $ 67,481   $ 67,481   $ 69,575
Net Income (Loss) Attributable to Parent $ 2,077 $ (1,116) $ 2,094 $ (3,269)  
v3.24.2
Note 6 - Goodwill (Details Textual)
$ in Thousands
9 Months Ended
Aug. 31, 2023
USD ($)
Goodwill, Impairment Loss $ 0
v3.24.2
Note 7 - Investment in Joint Venture (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended
Jan. 31, 2023
Jan. 10, 2023
Jan. 31, 2023
May 31, 2024
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Payments to Acquire Equity Method Investments             $ (0) $ 520
Income (Loss) from Equity Method Investments         $ 62 $ (171) 20 (338)
Income (Loss) from Equity Method Investments         (62) 171 (20) 338
Interest Income, Financing Receivable, before Allowance for Credit Loss         $ 30   $ 60  
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Secured Overnight Financing Rate (SOFR) [Member]              
Byrna LATAM [Member]                
Loans and Leases Receivable, Related Parties $ 1,600   $ 1,600          
Loans Receivable, Basis Spread on Variable Rate 3.00%   3.00%          
Financing Receivable, Interest Rate at Period End       8.30% 8.30%   8.30%  
Financing Receivable, Term (Year)     5 years          
Byrna LATAM [Member]                
Equity Method Investment, Ownership Percentage   51.00%            
Payments to Acquire Equity Method Investments   $ 500            
Income (Loss) from Equity Method Investments       $ 100   (200) $ 100 (300)
Income (Loss) from Equity Method Investments       $ (100)   $ 200 $ (100) $ 300
v3.24.2
Note 8 - Advertising Costs (Details Textual) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Advertising Expense $ 2.5 $ 0.6 $ 5.3 $ 1.5
v3.24.2
Note 9 - Revenue, Deferred Revenue and Accounts Receivable (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Nov. 30, 2023
Nov. 30, 2022
Standard Product Warranty, Term (Year)   1 year          
Extended Product Warranty, Term (Year) 3 years 3 years          
Accounts Receivable, after Allowance for Credit Loss, Current $ 1,635 $ 1,635   $ 1,635   $ 2,945 $ 5,900
Accounts Receivable, Allowance for Credit Loss 300 300   300   500 20
Contract with Customer, Liability $ 1,500 1,500 $ 600 1,500 $ 600 $ 1,900 $ 800
Contract with Customer, Liability, Revenue Recognized   $ 100 $ 80 $ 200 $ 100    
v3.24.2
Note 9 - Revenue, Deferred Revenue and Accounts Receivable - Revenue Disaggregation (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Revenues $ 20,269 $ 11,508 $ 36,923 $ 19,919
Wholesale (Dealer/Distributors and Large End-Users) [Member]        
Revenues 5,177 4,669 8,731 6,968
E-commerce [Member]        
Revenues $ 15,092 $ 6,839 $ 28,192 $ 12,951
v3.24.2
Note 10 - Inventory - Summary of Inventory (Details) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
Raw materials $ 9,645 $ 7,543
Work in process 2,122 2,439
Finished goods 3,733 3,908
Total $ 15,500 $ 13,890
v3.24.2
Note 11 - Property and Equipment (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Nov. 30, 2023
Depreciation $ 300 $ 200 $ 500 $ 400  
Deposits Assets, Noncurrent $ 1,706   $ 1,706   $ 1,163
v3.24.2
Note 11 - Property and Equipment - Summary of Cost and Accumulated Depreciation (Details) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
Property, plant and equipment, gross   $ 5,504
Less: accumulated depreciation   1,701
Total $ 3,408 3,803
Minimum [Member]    
Property, plant and equipment, gross 5,645  
Less: accumulated depreciation 2,237  
Total 3,408  
Computer Equipment and Software [Member]    
Property, plant and equipment, gross   817
Computer Equipment and Software [Member] | Minimum [Member]    
Property, plant and equipment, gross 814  
Furniture and Fixtures [Member]    
Property, plant and equipment, gross   273
Furniture and Fixtures [Member] | Minimum [Member]    
Property, plant and equipment, gross 274  
Leasehold Improvements [Member]    
Property, plant and equipment, gross   989
Leasehold Improvements [Member] | Minimum [Member]    
Property, plant and equipment, gross 990  
Machinery and Equipment [Member]    
Property, plant and equipment, gross   $ 3,425
Machinery and Equipment [Member] | Minimum [Member]    
Property, plant and equipment, gross $ 3,567  
v3.24.2
Note 12 - Intangible Assets (Details Textual) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Amortization of Intangible Assets $ 0.1 $ 0.1 $ 0.1 $ 0.1
v3.24.2
Note 12 - Intangible Assets - Components of Intangible Assets (Details) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
Intangible assets, gross carrying amount $ 4,361 $ 4,361
Intangible assets, accumulated amortization (920) (778)
Intangible assets, net carrying amount 3,441 3,583
Trademarks [Member]    
Intangible assets, gross carrying amount 360 360
Intangible assets, net carrying amount 360 360
Patents [Member]    
Intangible assets, gross carrying amount 3,931 3,931
Intangible assets, accumulated amortization (850) (723)
Intangible assets, net carrying amount $ 3,081 3,208
Patents [Member] | Minimum [Member]    
Finite lived intangible assets, useful life (Year) 10 years  
Patents [Member] | Maximum [Member]    
Finite lived intangible assets, useful life (Year) 17 years  
Customer Lists [Member]    
Finite lived intangible assets, useful life (Year) 2 years  
Intangible assets, gross carrying amount $ 70 70
Intangible assets, accumulated amortization (70) (55)
Intangible assets, net carrying amount $ 0 $ 15
v3.24.2
Note 12 - Intangible Assets - Estimated Future Amortization Expense (Details)
$ in Thousands
May 31, 2024
USD ($)
2024 (remaining six months) $ 128
2025 254
2026 254
2027 254
2028 254
Thereafter 1,937
Total $ 3,081
v3.24.2
Note 13 - Accounts Payable and Accrued Liabilities - Summary of Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
Trade payables $ 6,450 $ 2,617
Accrued sales and use tax 362 834
Accrued people costs 1,763 2,173
Accrued professional fees 148 201
Other accrued liabilities 484 333
Total $ 9,207 $ 6,158
v3.24.2
Note 14 - Stock-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Jun. 17, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)       244,465    
Restricted Stock Units (RSUs), Excluding Time-based Units [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)       600,000    
Restricted Stock Units (RSUs) [Member]            
Share-Based Payment Arrangement, Expense   $ 0.4 $ 1.0 $ 0.9 $ 2.0  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)       634,513    
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $ 1.9 $ 1.9   $ 1.9    
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)       2 years    
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)       658,281    
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)       68,940    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures (in shares)       589,341    
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 33.33%          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, 20 Day Volume Weighted Average Closing Price (in dollars per share) $ 6 $ 6   $ 6    
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Two [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 33.33%          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, 20 Day Volume Weighted Average Closing Price (in dollars per share) $ 9 9   9    
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Three [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 33.33%          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, 20 Day Volume Weighted Average Closing Price (in dollars per share) $ 12 $ 12   $ 12    
Restricted Stock Units (RSUs), Time-based [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       81,656 9,805  
Share-Based Payment Arrangement, Option [Member]            
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)   1 year 8 months 12 days        
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)       37,033    
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 2.5 $ 2.5   $ 2.5    
The 2020 Equity Incentive Plan (2020 Plan) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)           3,800,000
Share-Based Payment Arrangement, Expense   0.9 1.5 1.8 $ 3.0  
The 2020 Equity Incentive Plan (2020 Plan) [Member] | Share-Based Payment Arrangement, Option [Member] | Employees and Directors [Member]            
Share-Based Payment Arrangement, Expense   $ 0.5 $ 0.5 $ 0.9 $ 0.9  
v3.24.2
Note 14 - Stock-based Compensation - Valuation Assumptions (Details)
6 Months Ended
May 31, 2024
$ / shares
Restricted Stock Units (RSUs) [Member]  
Risk free rate 4.33%
Expected volatility 33.00%
Expected life (in years) (Year) 2 years 8 months 12 days
Market price of the Company’s common stock on date of grant (in dollars per share) $ 6.03
Share-Based Payment Arrangement, Option [Member]  
Risk free rate 4.10%
Expected volatility 75.75%
Expected life (in years) (Year) 6 years 6 months
Market price of the Company’s common stock on date of grant (in dollars per share) $ 6.89
Expected dividends 0.00%
v3.24.2
Note 14 - Stock-based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member]
6 Months Ended
May 31, 2024
shares
Unvested and outstanding, RSU (in shares) 976,226
Granted, RSU (in shares) 634,513
Settled, RSU (in shares) (658,281)
Forfeited, RSU (in shares) (75,250)
Unvested and outstanding, RSU (in shares) 877,208
v3.24.2
Note 14 - Stock-based Compensation - Summary of Stock Option Activity (Details) - $ / shares
6 Months Ended
May 31, 2024
Outstanding, stock options (in shares) 1,384,666
Outstanding, weighted-average exercise price per stock option (in dollars per share) $ 7.12
Granted, stock options (in shares) 199,500
Granted, weighted-average exercise price per share (in dollars per share) $ 6.89
Exercised, stock options (in shares) (244,465)
Exercised, weighted-average exercise price per share (in dollars per share) $ (2.2)
Outstanding, stock options (in shares) 1,339,701
Outstanding, weighted-average exercise price per stock option (in dollars per share) $ 9
Exercisable, stock options (in shares) 673,602
Exercisable, weighted-average exercise price per share (in dollars per share) $ 9.41
v3.24.2
Note 15 - Earnings Per Share - Allocation of Net Income (Loss) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Net income (loss) for the period $ 2,077 $ (1,116) $ 2,094 $ (3,269)
Weighted-average number of common shares outstanding - basic (in shares) 22,728,500 21,866,260 22,383,769 21,863,263
Basic net income (loss) per share (in dollars per share) $ 0.09 $ (0.05) $ 0.09 $ (0.15)
Weighted-average number of common shares outstanding - diluted (in shares) 23,731,076 21,866,260 22,942,530 21,863,263
Diluted net income (loss) per share (in dollars per share) $ 0.09 $ (0.05) $ 0.09 $ (0.15)
v3.24.2
Note 15 - Earnings Per Share - Weighted-average Number of Shares Outstanding Reconciliation (Details) - shares
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Weighted-average number of common shares outstanding - basic (in shares) 22,728,500 21,866,260 22,383,769 21,863,263
Dilutive stock options (in shares) 315,374 0 117,374 0
Dilutive RSUs (in shares) 687,202 0 441,387 0
Weighted-average common share outstanding- diluted (in shares) 23,731,076 21,866,260 22,942,530 21,863,263
v3.24.2
Note 15 - Earnings Per Share - Summary of Antidilutive Securities (Details) - shares
3 Months Ended 6 Months Ended 15 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Antidilutive securities (in shares) 36,000 2,768,682 676,679 2,843,682
Share-Based Payment Arrangement, Option [Member]        
Antidilutive securities (in shares) 36,000 1,514,416 452,166 1,514,416
Restricted Stock Units (RSUs) [Member]        
Antidilutive securities (in shares) 0 1,254,266 224,513 1,254,266
v3.24.2
Note 16 - Related Party Transactions (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 07, 2023
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Nov. 30, 2023
Nov. 30, 2022
Each of Four Individual Investors [Member] | Fusady [Member]              
Subsidiary, Ownership Percentage, Noncontrolling Owner   25.00%   25.00%      
Each of Four Individual Investors [Member] | Bersa S.A [Member]              
Subsidiary, Ownership Percentage, Noncontrolling Owner   25.00%   25.00%      
Bersa S.A [Member]              
Accounts Receivable, after Allowance for Credit Loss   $ 0   $ 0   $ 1,600  
Bersa S.A [Member] | Related Party [Member]              
Revenues   $ 100 $ 50 $ 100 $ 100    
Restricted Stock Units (RSUs) [Member] | Chief Technology Officer [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)             200,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares) 200,000         200,000  
Share-Based Payment Arrangement, Accelerated Cost           $ 500  
v3.24.2
Note 17 - Leases (Details Textual)
3 Months Ended
May 31, 2024
Wilmington/Andover, Massachusetts [Member]  
Lease Expiration Date Feb. 29, 2028
Fort Wayne, Indiana [Member] | Former Fort Wayne Facility Member  
Lease Expiration Date Jul. 31, 2025
Las Vegas, Nevada [Member]  
Lease Expiration Date Jan. 31, 2027
v3.24.2
Note 17 - Leases - Elements of Lease Expense (Details)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
USD ($)
May 31, 2024
USD ($)
Operating lease cost $ 243 $ 397
Cash paid for amounts included in the measurement of operating lease liabilities 258 426
Operating lease liabilities arising from obtaining right-of-use assets $ 0 $ 0
Operating Leases, Weighted-average remaining lease term (Year) 3 years 2 months 12 days 3 years 2 months 12 days
Weighted-average discount rate 9.60% 9.60%
v3.24.2
Note 17 - Leases - Future Lease Payments Under Non-cancelable Operating Leases (Details) - USD ($)
$ in Thousands
May 31, 2024
Nov. 30, 2023
2024 (six months) $ 303  
2025 523  
2026 527  
2027 394  
2028 53  
Total lease payments 1,800  
Less: imputed interest 249  
Present value of operating lease liabilities 1,551  
Operating lease liabilities, current 552 $ 644
Operating lease liabilities, non-current $ 999 $ 1,258
v3.24.2
Note 18 - Income Taxes (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Income Tax Expense (Benefit) $ 3 $ 17 $ 3 $ (41)
Effective Income Tax Rate Reconciliation, Percent 0.10% 1.60% 0.20% (1.30%)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%      
v3.24.2
Note 19 - Commitments and Contingencies (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 07, 2023
Apr. 13, 2018
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Nov. 30, 2023
Jan. 07, 2022
Restricted Stock Units (RSUs) [Member]                
Share-Based Payment Arrangement, Expense     $ 400 $ 1,000 $ 900 $ 2,000    
Restricted Stock Units (RSUs) [Member] | Chief Technology Officer [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)               200,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares) 200,000           200,000  
Share-Based Payment Arrangement, Expense             $ 1,000  
Fintail Projectiles [Member]                
Initial Royalty, Percentage of Net Price   4.00%            
Andre Buys [Member]                
Other Commitment, to be Paid, Year One   $ 30            
v3.24.2
Note 20 - Segment and Geographical Disclosures (Details Textual)
3 Months Ended
May 31, 2024
Number of Reportable Segments 1
v3.24.2
Note 20 - Segment and Geographical Disclosures - Summary of Revenue, Long-lived Assets and Total Assets by Geographical Region (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Revenue $ 20,269 $ 11,508 $ 36,923 $ 19,919
UNITED STATES        
Revenue 18,659 10,004 34,197 17,996
SOUTH AFRICA        
Revenue 41 178 104 211
Europe/South America/Asia [Member]        
Revenue 1,015 1,082 1,532 1,207
CANADA        
Revenue $ 554 $ 244 $ 1,090 $ 505
v3.24.2
Note 21 - Financial Instruments (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 31, 2024
May 31, 2023
May 31, 2024
May 31, 2023
Jan. 31, 2023
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent $ 144 $ (641) $ 29 $ (1,226)  
US Tax Rate Percentage of Fluctuation 10.00%        
Byrna LATAM [Member]          
Loans and Leases Receivable, Related Parties         $ 1,600
SOUTH AFRICA          
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent     $ 30 $ (1,200)  

Byrna Technologies (NASDAQ:BYRN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Byrna Technologies Charts.
Byrna Technologies (NASDAQ:BYRN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Byrna Technologies Charts.